---
---

# 42 U.S.C., USLM ref /us/usc/t42/ch6A

* Portions Copyright © 2016 the authors of the https://github.com/publicdocs project.
  Use of this file is subject to the NOTICE at [https://github.com/publicdocs/uscode/blob/master/NOTICE](https://github.com/publicdocs/uscode/blob/master/NOTICE)
* See the [Document Metadata](././../../../..//README.md) for more information.
  This file is generated from historical government data; content and/or formatting may be inaccurate and out-of-date and should not be used for official purposes.

----------
----------

[Previous](./../../../..//us/usc/t42/ch6/m__us_usc_t42_s194.md) | [Next](./../../../..//us/usc/t42/ch6A/schI/m__us_usc_t42_ch6A_schI.md) | [Root of Title](./../../../../) | [Other Versions of this Document](https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft42%2Fch6A)

## CHAPTER 6A—PUBLIC HEALTH SERVICE

<table>

  <tr>

    <td> 

SUBCHAPTER I—ADMINISTRATION AND MISCELLANEOUS PROVISIONS  </td>

  </tr>

  <tr>

    <td> Sec.  </td>

  </tr>

  <tr>

    <td> 201.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 

Part A—Administration  </td>

  </tr>

  <tr>

    <td> 202.  </td>

    <td> Administration and supervision of Service.  </td>

  </tr>

  <tr>

    <td> 203.  </td>

    <td> Organization of Service.  </td>

  </tr>

  <tr>

    <td> 204.  </td>

    <td> Commissioned Corps and Ready Reserve Corps.  </td>

  </tr>

  <tr>

    <td> 204a.  </td>

    <td> Deployment readiness.  </td>

  </tr>

  <tr>

    <td> 205.  </td>

    <td> Appointment and tenure of office of Surgeon General; reversion in rank.  </td>

  </tr>

  <tr>

    <td> 206.  </td>

    <td> Assignment of officers.  </td>

  </tr>

  <tr>

    <td> 207.  </td>

    <td> Grades, ranks, and titles of commissioned corps.  </td>

  </tr>

  <tr>

    <td> 208.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 209.  </td>

    <td> Appointment of personnel.  </td>

  </tr>

  <tr>

    <td> 209a to 209c.  </td>

    <td> Omitted or Repealed.  </td>

  </tr>

  <tr>

    <td> 209d.  </td>

    <td> Appointment of osteopaths as commissioned officers.  </td>

  </tr>

  <tr>

    <td> 210.  </td>

    <td> Pay and allowances.  </td>

  </tr>

  <tr>

    <td> 210–1.  </td>

    <td> Annual and sick leave.  </td>

  </tr>

  <tr>

    <td> 210a.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 210b.  </td>

    <td> Professional categories.  </td>

  </tr>

  <tr>

    <td> 211.  </td>

    <td> Promotion of commissioned officers.  </td>

  </tr>

  <tr>

    <td> 211a, 211b.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 211c.  </td>

    <td> Promotion credit for medical officers in assistant grade.  </td>

  </tr>

  <tr>

    <td> 212.  </td>

    <td> Retirement of commissioned officers.  </td>

  </tr>

  <tr>

    <td> 212a, 212b.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 213.  </td>

    <td> Military benefits.  </td>

  </tr>

  <tr>

    <td> 213a.  </td>

    <td> Rights, benefits, privileges, and immunities for commissioned officers or beneficiaries; exercise of authority by Secretary or designee.  </td>

  </tr>

  <tr>

    <td> 214.  </td>

    <td> Presentation of United States flag upon retirement.  </td>

  </tr>

  <tr>

    <td> 214a.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 215.  </td>

    <td> Detail of Service personnel.  </td>

  </tr>

  <tr>

    <td> 216.  </td>

    <td> Regulations.  </td>

  </tr>

  <tr>

    <td> 217.  </td>

    <td> Use of Service in time of war or emergency.  </td>

  </tr>

  <tr>

    <td> 217a.  </td>

    <td> Advisory councils or committees.  </td>

  </tr>

  <tr>

    <td> 217a–1.  </td>

    <td> Advisory committees; prohibition of consideration of political affiliations.  </td>

  </tr>

  <tr>

    <td> 217b.  </td>

    <td> Volunteer services.  </td>

  </tr>

  <tr>

    <td> 218.  </td>

    <td> National Advisory Councils on Migrant Health.  </td>

  </tr>

  <tr>

    <td> 218a.  </td>

    <td> Training of officers.  </td>

  </tr>

  <tr>

    <td> 219 to 230.  </td>

    <td> Transferred, Repealed, or Omitted.  </td>

  </tr>

  <tr>

    <td> 231.  </td>

    <td> Service and supply fund; uses; reimbursement.  </td>

  </tr>

  <tr>

    <td> 232.  </td>

    <td> National Institute of Mental Health; authorization of appropriation; construction; location.  </td>

  </tr>

  <tr>

    <td> 233.  </td>

    <td> Civil actions or proceedings against commissioned officers or employees.  </td>

  </tr>

  <tr>

    <td> 234.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 235.  </td>

    <td> Administration of grants in multigrant projects; promulgation of regulations.  </td>

  </tr>

  <tr>

    <td> 236.  </td>

    <td> Orphan Products Board.  </td>

  </tr>

  <tr>

    <td> 237.  </td>

    <td> Silvio O. Conte Senior Biomedical Research Service.  </td>

  </tr>

  <tr>

    <td> 237a.  </td>

    <td> Health and Human Services Office on Women’s Health.  </td>

  </tr>

  <tr>

    <td> 

Part B—Miscellaneous Provisions  </td>

  </tr>

  <tr>

    <td> 238.  </td>

    <td> Gifts for benefit of Service.  </td>

  </tr>

  <tr>

    <td> 238a.  </td>

    <td> Use of immigration station hospitals.  </td>

  </tr>

  <tr>

    <td> 238b.  </td>

    <td> Disposition of money collected for care of patients.  </td>

  </tr>

  <tr>

    <td> 238c.  </td>

    <td> Transportation of remains of officers.  </td>

  </tr>

  <tr>

    <td> 238d.  </td>

    <td> Availability of appropriations for grants to Federal institutions.  </td>

  </tr>

  <tr>

    <td> 238e.  </td>

    <td> Transfer of funds.  </td>

  </tr>

  <tr>

    <td> 238f.  </td>

    <td> Availability of appropriations.  </td>

  </tr>

  <tr>

    <td> 238g.  </td>

    <td> Wearing of uniforms.  </td>

  </tr>

  <tr>

    <td> 238h.  </td>

    <td> Biennial report.  </td>

  </tr>

  <tr>

    <td> 238i.  </td>

    <td> Memorials and other acknowledgments for contributions to health of Nation.  </td>

  </tr>

  <tr>

    <td> 238j.  </td>

    <td> Evaluation of programs.  </td>

  </tr>

  <tr>

    <td> 238k.  </td>

    <td> Contract authority.  </td>

  </tr>

  <tr>

    <td> 238l.  </td>

    <td> Recovery.  </td>

  </tr>

  <tr>

    <td> 238m.  </td>

    <td> Use of fiscal agents.  </td>

  </tr>

  <tr>

    <td> 238n.  </td>

    <td> Abortion-related discrimination in governmental activities regarding training and licensing of physicians.  </td>

  </tr>

  <tr>

    <td> 238o.  </td>

    <td> Restriction on use of funds for assisted suicide, euthanasia, and mercy killing.  </td>

  </tr>

  <tr>

    <td> 238p.  </td>

    <td> Recommendations and guidelines regarding automated external defibrillators for Federal buildings.  </td>

  </tr>

  <tr>

    <td> 238q.  </td>

    <td> Liability regarding emergency use of automated external defibrillators.  </td>

  </tr>

  <tr>

    <td> 

Part C—Smallpox Emergency Personnel Protection  </td>

  </tr>

  <tr>

    <td> 239.  </td>

    <td> General provisions.  </td>

  </tr>

  <tr>

    <td> 239a.  </td>

    <td> Determination of eligibility and benefits.  </td>

  </tr>

  <tr>

    <td> 239b.  </td>

    <td> Smallpox vaccine injury table.  </td>

  </tr>

  <tr>

    <td> 239c.  </td>

    <td> Medical benefits.  </td>

  </tr>

  <tr>

    <td> 239d.  </td>

    <td> Compensation for lost employment income.  </td>

  </tr>

  <tr>

    <td> 239e.  </td>

    <td> Payment for death.  </td>

  </tr>

  <tr>

    <td> 239f.  </td>

    <td> Administration.  </td>

  </tr>

  <tr>

    <td> 239g.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 239h.  </td>

    <td> Relationship to other laws.  </td>

  </tr>

  <tr>

    <td> 

Part D—United States Public Health Sciences Track  </td>

  </tr>

  <tr>

    <td> 239l.  </td>

    <td> Establishment.  </td>

  </tr>

  <tr>

    <td> 239l–1.  </td>

    <td> Administration.  </td>

  </tr>

  <tr>

    <td> 239l–2.  </td>

    <td> Students; selection; obligation.  </td>

  </tr>

  <tr>

    <td> 239l–3.  </td>

    <td> Funding.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER II—GENERAL POWERS AND DUTIES  </td>

  </tr>

  <tr>

    <td> 

Part A—Research and Investigations  </td>

  </tr>

  <tr>

    <td> 241.  </td>

    <td> Research and investigations generally.  </td>

  </tr>

  <tr>

    <td> 242.  </td>

    <td> Studies and investigations on use and misuse of narcotic drugs and other drugs; annual report to Attorney General; cooperation with States.  </td>

  </tr>

  <tr>

    <td> 242a.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 242b.  </td>

    <td> General authority respecting research, evaluations, and demonstrations in health statistics, health services, and health care technology.  </td>

  </tr>

  <tr>

    <td> 242c to 242j.  </td>

    <td> Repealed or Transferred.  </td>

  </tr>

  <tr>

    <td> 242k.  </td>

    <td> National Center for Health Statistics.  </td>

  </tr>

  <tr>

    <td> 242l.  </td>

    <td> International cooperation.  </td>

  </tr>

  <tr>

    <td> 242m.  </td>

    <td> General provisions respecting effectiveness, efficiency, and quality of health services.  </td>

  </tr>

  <tr>

    <td> 242n.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 242o.  </td>

    <td> Health conferences; publication of health educational information.  </td>

  </tr>

  <tr>

    <td> 242p.  </td>

    <td> National disease prevention data profile.  </td>

  </tr>

  <tr>

    <td> 242q.  </td>

    <td> Task Force on Aging Research; establishment and duties.  </td>

  </tr>

  <tr>

    <td> 242q–1.  </td>

    <td> Membership.  </td>

  </tr>

  <tr>

    <td> 242q–2.  </td>

    <td> Administrative staff and support.  </td>

  </tr>

  <tr>

    <td> 242q–3.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 242q–4.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 242q–5.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 242r.  </td>

    <td> Improvement and publication of data on food-related allergic responses.  </td>

  </tr>

  <tr>

    <td> 242s.  </td>

    <td> Centers for Disease Control and Prevention Office of Women’s Health.  </td>

  </tr>

  <tr>

    <td> 

Part B—Federal-State Cooperation  </td>

  </tr>

  <tr>

    <td> 243.  </td>

    <td> General grant of authority for cooperation.  </td>

  </tr>

  <tr>

    <td> 244.  </td>

    <td> Public access defibrillation programs.  </td>

  </tr>

  <tr>

    <td> 244–1, 244a.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 245.  </td>

    <td> Public access defibrillation demonstration projects.  </td>

  </tr>

  <tr>

    <td> 245a.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 246.  </td>

    <td> Grants and services to States.  </td>

  </tr>

  <tr>

    <td> 246a.  </td>

    <td> Bureau of State Services management fund; establishment; advancements; availability.  </td>

  </tr>

  <tr>

    <td> 247.  </td>

    <td> Omitted.  </td>

  </tr>

  <tr>

    <td> 247a.  </td>

    <td> Family support groups for Alzheimer’s disease patients.  </td>

  </tr>

  <tr>

    <td> 247b.  </td>

    <td> Project grants for preventive health services.  </td>

  </tr>

  <tr>

    <td> 247b–1.  </td>

    <td> Screenings, referrals, and education regarding lead poisoning.  </td>

  </tr>

  <tr>

    <td> 247b–2.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 247b–3.  </td>

    <td> Education, technology assessment, and epidemiology regarding lead poisoning.  </td>

  </tr>

  <tr>

    <td> 247b–3a.  </td>

    <td> Training and reports by the Health Resources and Services Administration.  </td>

  </tr>

  <tr>

    <td> 247b–4.  </td>

    <td> National Center on Birth Defects and Developmental Disabilities.  </td>

  </tr>

  <tr>

    <td> 247b–4a.  </td>

    <td> Early detection, diagnosis, and interventions for newborns and infants with hearing loss.  </td>

  </tr>

  <tr>

    <td> 247b–4b to 247b–4e.   </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 247b–4f.  </td>

    <td> Research relating to preterm labor and delivery and the care, treatment, and outcomes of preterm and low birthweight infants.  </td>

  </tr>

  <tr>

    <td> 247b–4g.  </td>

    <td> Interagency Coordinating Council on Prematurity and Low Birthweight.  </td>

  </tr>

  <tr>

    <td> 247b–5.  </td>

    <td> Preventive health measures with respect to prostate cancer.  </td>

  </tr>

  <tr>

    <td> 247b–6.  </td>

    <td> National strategy for combating and eliminating tuberculosis.  </td>

  </tr>

  <tr>

    <td> 247b–7.  </td>

    <td> Loan repayment program.  </td>

  </tr>

  <tr>

    <td> 247b–8.  </td>

    <td> Fellowship and training programs.  </td>

  </tr>

  <tr>

    <td> 247b–9.  </td>

    <td> Diabetes in children and youth.  </td>

  </tr>

  <tr>

    <td> 247b–9a.  </td>

    <td> Better diabetes care.  </td>

  </tr>

  <tr>

    <td> 247b–10.  </td>

    <td> Compilation of data on asthma.  </td>

  </tr>

  <tr>

    <td> 247b–11.  </td>

    <td> Effects of folic acid in prevention of birth defects.  </td>

  </tr>

  <tr>

    <td> 247b–12.  </td>

    <td> Safe motherhood.  </td>

  </tr>

  <tr>

    <td> 247b–13.  </td>

    <td> Prenatal and postnatal health.  </td>

  </tr>

  <tr>

    <td> 247b–14.  </td>

    <td> Oral health promotion and disease prevention.  </td>

  </tr>

  <tr>

    <td> 247b–14a.  </td>

    <td> Identification of interventions that reduce the burden and transmission of oral, dental, and craniofacial diseases in high risk populations; development of approaches for pediatric oral and craniofacial assessment.  </td>

  </tr>

  <tr>

    <td> 247b–15.  </td>

    <td> Surveillance and education regarding hepatitis C virus.  </td>

  </tr>

  <tr>

    <td> 247b–16.  </td>

    <td> Grants for lead poisoning related activities.  </td>

  </tr>

  <tr>

    <td> 247b–17.  </td>

    <td> Human papillomavirus (Johanna’s Law).  </td>

  </tr>

  <tr>

    <td> 247b–18.  </td>

    <td> Surveillance and research regarding muscular dystrophy.  </td>

  </tr>

  <tr>

    <td> 247b–19.  </td>

    <td> Information and education.  </td>

  </tr>

  <tr>

    <td> 247b–20.  </td>

    <td> Food safety grants.  </td>

  </tr>

  <tr>

    <td> 247b–21.  </td>

    <td> Mosquito-borne diseases; coordination grants to States; assessment and control grants to political subdivisions.  </td>

  </tr>

  <tr>

    <td> 247b–22.  </td>

    <td> Microbicide research.  </td>

  </tr>

  <tr>

    <td> 247c.  </td>

    <td> Sexually transmitted diseases; prevention and control projects and programs.  </td>

  </tr>

  <tr>

    <td> 247c–1.  </td>

    <td> Infertility and sexually transmitted diseases.  </td>

  </tr>

  <tr>

    <td> 247c–2.  </td>

    <td> Data collection regarding programs under subchapter XXIV.  </td>

  </tr>

  <tr>

    <td> 247d.  </td>

    <td> Public health emergencies.  </td>

  </tr>

  <tr>

    <td> 247d–1.  </td>

    <td> Vaccine tracking and distribution.  </td>

  </tr>

  <tr>

    <td> 247d–2, 247d–3.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 247d–3a.  </td>

    <td> Improving State and local public health security.  </td>

  </tr>

  <tr>

    <td> 247d–3b.  </td>

    <td> Partnerships for State and regional hospital preparedness to improve surge capacity.  </td>

  </tr>

  <tr>

    <td> 247d–4.  </td>

    <td> Revitalizing the Centers for Disease Control and Prevention.  </td>

  </tr>

  <tr>

    <td> 247d–5.  </td>

    <td> Combating antimicrobial resistance.  </td>

  </tr>

  <tr>

    <td> 247d–5a.  </td>

    <td> Identification of clinically susceptible concentrations of antimicrobials.  </td>

  </tr>

  <tr>

    <td> 247d–6.  </td>

    <td> Public health countermeasures to a bioterrorist attack.  </td>

  </tr>

  <tr>

    <td> 247d–6a.  </td>

    <td> Authority for use of certain procedures regarding qualified countermeasure research and development activities.  </td>

  </tr>

  <tr>

    <td> 247d–6b.  </td>

    <td> Strategic National Stockpile and security countermeasure procurements.  </td>

  </tr>

  <tr>

    <td> 247d–6c.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 247d–6d.  </td>

    <td> Targeted liability protections for pandemic and epidemic products and security countermeasures.  </td>

  </tr>

  <tr>

    <td> 247d–6e.  </td>

    <td> Covered countermeasure process.  </td>

  </tr>

  <tr>

    <td> 247d–7.  </td>

    <td> Demonstration program to enhance bioterrorism training, coordination, and readiness.  </td>

  </tr>

  <tr>

    <td> 247d–7a.  </td>

    <td> Grants regarding training and education of certain health professionals.  </td>

  </tr>

  <tr>

    <td> 247d–7b.  </td>

    <td> Emergency system for advance registration of health professions volunteers.  </td>

  </tr>

  <tr>

    <td> 247d–7c.  </td>

    <td> Supplies and services in lieu of award funds.  </td>

  </tr>

  <tr>

    <td> 247d–7d.  </td>

    <td> Security for countermeasure development and production.  </td>

  </tr>

  <tr>

    <td> 247d–7e.  </td>

    <td> Biomedical Advanced Research and Development Authority.  </td>

  </tr>

  <tr>

    <td> 247d–7f.  </td>

    <td> National Biodefense Science Board and working groups.  </td>

  </tr>

  <tr>

    <td> 247d–8.  </td>

    <td> Coordinated program to improve pediatric oral health.  </td>

  </tr>

  <tr>

    <td> 247d–9.  </td>

    <td> Dental education for parents of newborns.  </td>

  </tr>

  <tr>

    <td> 

Part C—Hospitals, Medical Examinations, and Medical Care  </td>

  </tr>

  <tr>

    <td> 247e.  </td>

    <td> National Hansen’s Disease Programs Center.  </td>

  </tr>

  <tr>

    <td> 248.  </td>

    <td> Control and management of hospitals; furnishing prosthetic and orthopedic devices; transfer of patients; disposal of articles produced by patients; disposal of money and effects of deceased patients; payment of burial expenses.  </td>

  </tr>

  <tr>

    <td> 248a.  </td>

    <td> Closing or transfer of hospitals; reduction of services; Congressional authorization required.  </td>

  </tr>

  <tr>

    <td> 248b.  </td>

    <td> Transfer or financial self-sufficiency of public health service hospitals and clinics.  </td>

  </tr>

  <tr>

    <td> 248c, 248d.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 249.  </td>

    <td> Medical care and treatment of quarantined and detained persons.  </td>

  </tr>

  <tr>

    <td> 250.  </td>

    <td> Medical care and treatment of Federal prisoners.  </td>

  </tr>

  <tr>

    <td> 250a.  </td>

    <td> Transfer of appropriations.  </td>

  </tr>

  <tr>

    <td> 251.  </td>

    <td> Medical examination and treatment of Federal employees; medical care at remote stations.  </td>

  </tr>

  <tr>

    <td> 252.  </td>

    <td> Medical examination of aliens.  </td>

  </tr>

  <tr>

    <td> 253.  </td>

    <td> Medical services to Coast Guard, National Oceanic and Atmospheric Administration, and Public Health Service.  </td>

  </tr>

  <tr>

    <td> 253a.  </td>

    <td> Medical services to retired personnel of National Oceanic and Atmospheric Administration.  </td>

  </tr>

  <tr>

    <td> 253b.  </td>

    <td> Former Lighthouse Service employees; medical service eligibility.  </td>

  </tr>

  <tr>

    <td> 254.  </td>

    <td> Interdepartmental work.  </td>

  </tr>

  <tr>

    <td> 254a.  </td>

    <td> Sharing of medical care facilities and resources.  </td>

  </tr>

  <tr>

    <td> 

Part D—Primary Health Care  </td>

  </tr>

  <tr>

    <td> 

subpart i—health centers  </td>

  </tr>

  <tr>

    <td> 254b.  </td>

    <td> Health centers.  </td>

  </tr>

  <tr>

    <td> 254b–1.  </td>

    <td> State grants to health care providers who provide services to a high percentage of medically underserved populations or other special populations.  </td>

  </tr>

  <tr>

    <td> 254b–2.  </td>

    <td> Community health centers and the National Health Service Corps Fund.  </td>

  </tr>

  <tr>

    <td> 254c.  </td>

    <td> Rural health care services outreach, rural health network development, and small health care provider quality improvement grant programs.  </td>

  </tr>

  <tr>

    <td> 254c–1.  </td>

    <td> Grants for health services for Pacific Islanders.  </td>

  </tr>

  <tr>

    <td> 254c–1a.  </td>

    <td> Grants to nurse-managed health clinics.  </td>

  </tr>

  <tr>

    <td> 254c–2.  </td>

    <td> Special diabetes programs for type I diabetes.  </td>

  </tr>

  <tr>

    <td> 254c–3.  </td>

    <td> Special diabetes programs for Indians.  </td>

  </tr>

  <tr>

    <td> 254c–4.  </td>

    <td> Centers for strategies on facilitating utilization of preventive health services among various populations.  </td>

  </tr>

  <tr>

    <td> 254c–5.  </td>

    <td> Epilepsy; seizure disorder.  </td>

  </tr>

  <tr>

    <td> 254c–6.  </td>

    <td> Certain services for pregnant women.  </td>

  </tr>

  <tr>

    <td> 254c–7.  </td>

    <td> Special needs adoption programs; public awareness campaign and other activities.  </td>

  </tr>

  <tr>

    <td> 254c–8.  </td>

    <td> Healthy start for infants.  </td>

  </tr>

  <tr>

    <td> 254c–9.  </td>

    <td> Establishment of program of grants.  </td>

  </tr>

  <tr>

    <td> 254c–10.  </td>

    <td> Certain requirements.  </td>

  </tr>

  <tr>

    <td> 254c–11.  </td>

    <td> Technical assistance.  </td>

  </tr>

  <tr>

    <td> 254c–12.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 254c–13.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 254c–14.  </td>

    <td> Telehealth network and telehealth resource centers grant programs.  </td>

  </tr>

  <tr>

    <td> 254c–15.  </td>

    <td> Rural emergency medical service training and equipment assistance program.  </td>

  </tr>

  <tr>

    <td> 254c–16.  </td>

    <td> Mental health services delivered via telehealth.  </td>

  </tr>

  <tr>

    <td> 254c–17.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 254c–18.  </td>

    <td> Telemedicine; incentive grants regarding coordination among States.  </td>

  </tr>

  <tr>

    <td> 

subpart ii—national health service corps program  </td>

  </tr>

  <tr>

    <td> 254d.  </td>

    <td> National Health Service Corps.  </td>

  </tr>

  <tr>

    <td> 254e.  </td>

    <td> Health professional shortage areas.  </td>

  </tr>

  <tr>

    <td> 254f.  </td>

    <td> Corps personnel.  </td>

  </tr>

  <tr>

    <td> 254f–1.  </td>

    <td> Priorities in assignment of Corps personnel.  </td>

  </tr>

  <tr>

    <td> 254g.  </td>

    <td> Charges for services by entities using Corps members.  </td>

  </tr>

  <tr>

    <td> 254h.  </td>

    <td> Provision of health services by Corps members.  </td>

  </tr>

  <tr>

    <td> 254h–1.  </td>

    <td> Facilitation of effective provision of Corps services.  </td>

  </tr>

  <tr>

    <td> 254i.  </td>

    <td> Annual report to Congress; contents.  </td>

  </tr>

  <tr>

    <td> 254j.  </td>

    <td> National Advisory Council on National Health Service Corps.  </td>

  </tr>

  <tr>

    <td> 254k.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 

subpart iii—scholarship program and loan repayment program  </td>

  </tr>

  <tr>

    <td> 254l.  </td>

    <td> National Health Service Corps Scholarship Program.  </td>

  </tr>

  <tr>

    <td> 254l–1.  </td>

    <td> National Health Service Corps Loan Repayment Program.  </td>

  </tr>

  <tr>

    <td> 254m.  </td>

    <td> Obligated service under contract.  </td>

  </tr>

  <tr>

    <td> 254n.  </td>

    <td> Private practice.  </td>

  </tr>

  <tr>

    <td> 254o.  </td>

    <td> Breach of scholarship contract or loan repayment contract.  </td>

  </tr>

  <tr>

    <td> 254o–1.  </td>

    <td> Fund regarding use of amounts recovered for contract breach to replace services lost as result of breach.  </td>

  </tr>

  <tr>

    <td> 254p.  </td>

    <td> Special loans for former Corps members to enter private practice.  </td>

  </tr>

  <tr>

    <td> 254q.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 254q–1.  </td>

    <td> Grants to States for loan repayment programs.  </td>

  </tr>

  <tr>

    <td> 254r.  </td>

    <td> Grants to States for operation of offices of rural health.  </td>

  </tr>

  <tr>

    <td> 254s.  </td>

    <td> Native Hawaiian Health Scholarships.  </td>

  </tr>

  <tr>

    <td> 254t.  </td>

    <td> Demonstration project.  </td>

  </tr>

  <tr>

    <td> 254u.  </td>

    <td> Public health departments.  </td>

  </tr>

  <tr>

    <td> 

subpart iv—home health services  </td>

  </tr>

  <tr>

    <td> 255.  </td>

    <td> Home health services.  </td>

  </tr>

  <tr>

    <td> 

subpart v—healthy communities access program  </td>

  </tr>

  <tr>

    <td> 256.  </td>

    <td> Grants to strengthen the effectiveness, efficiency, and coordination of services for the uninsured and underinsured.  </td>

  </tr>

  <tr>

    <td> 256a.  </td>

    <td> Patient navigator grants.  </td>

  </tr>

  <tr>

    <td> 256a–1.  </td>

    <td> Establishing community health teams to support the patient-centered medical home.  </td>

  </tr>

  <tr>

    <td> 

subpart vii—drug pricing agreements  </td>

  </tr>

  <tr>

    <td> 256b.  </td>

    <td> Limitation on prices of drugs purchased by covered entities.  </td>

  </tr>

  <tr>

    <td> 

subpart viii—bulk purchases of vaccines for certain programs  </td>

  </tr>

  <tr>

    <td> 256c.  </td>

    <td> Bulk purchases of vaccines for certain programs.  </td>

  </tr>

  <tr>

    <td> 256d.  </td>

    <td> Breast and cervical cancer information.  </td>

  </tr>

  <tr>

    <td> 

subpart ix—support of graduate medical education programs in children’s hospitals  </td>

  </tr>

  <tr>

    <td> 256e.  </td>

    <td> Program of payments to children’s hospitals that operate graduate medical education programs.  </td>

  </tr>

  <tr>

    <td> 

subpart x—primary dental programs  </td>

  </tr>

  <tr>

    <td> 256f.  </td>

    <td> Designated dental health professional shortage area.  </td>

  </tr>

  <tr>

    <td> 256g.  </td>

    <td> Grants for innovative programs.  </td>

  </tr>

  <tr>

    <td> 256g–1.  </td>

    <td> Demonstration program to increase access to dental health care services.  </td>

  </tr>

  <tr>

    <td> 

subpart xi—support of graduate medical education in qualified teaching health centers  </td>

  </tr>

  <tr>

    <td> 256h.  </td>

    <td> Program of payments to teaching health centers that operate graduate medical education programs.  </td>

  </tr>

  <tr>

    <td> 

subpart xii—community-based collaborative care network program  </td>

  </tr>

  <tr>

    <td> 256i.  </td>

    <td> Community-based collaborative care network program.  </td>

  </tr>

  <tr>

    <td> 

Part E—Narcotic Addicts and Other Drug Abusers  </td>

  </tr>

  <tr>

    <td> 257 to 261a. Repealed or Transferred.  </td>

  </tr>

  <tr>

    <td> 

Part F—Licensing of Biological Products and Clinical Laboratories  </td>

  </tr>

  <tr>

    <td> 

subpart 1—biological products  </td>

  </tr>

  <tr>

    <td> 262.  </td>

    <td> Regulation of biological products.  </td>

  </tr>

  <tr>

    <td> 262a.  </td>

    <td> Enhanced control of dangerous biological agents and toxins.  </td>

  </tr>

  <tr>

    <td> 263.  </td>

    <td> Preparation of biological products by Service.  </td>

  </tr>

  <tr>

    <td> 

subpart 2—clinical laboratories  </td>

  </tr>

  <tr>

    <td> 263a.  </td>

    <td> Certification of laboratories.  </td>

  </tr>

  <tr>

    <td> 263a–1.  </td>

    <td> Assisted reproductive technology programs.  </td>

  </tr>

  <tr>

    <td> 263a–2.  </td>

    <td> Certification of embryo laboratories.  </td>

  </tr>

  <tr>

    <td> 263a–3.  </td>

    <td> Accreditation organizations.  </td>

  </tr>

  <tr>

    <td> 263a–4.  </td>

    <td> Certification revocation and suspension.  </td>

  </tr>

  <tr>

    <td> 263a–5.  </td>

    <td> Publication.  </td>

  </tr>

  <tr>

    <td> 263a–6.  </td>

    <td> Fees.  </td>

  </tr>

  <tr>

    <td> 263a–7.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 

subpart 3—mammography facilities  </td>

  </tr>

  <tr>

    <td> 263b.  </td>

    <td> Certification of mammography facilities.  </td>

  </tr>

  <tr>

    <td> 

Part G—Quarantine and Inspection  </td>

  </tr>

  <tr>

    <td> 264.  </td>

    <td> Regulations to control communicable diseases.  </td>

  </tr>

  <tr>

    <td> 265.  </td>

    <td> Suspension of entries and imports from designated places to prevent spread of communicable diseases.  </td>

  </tr>

  <tr>

    <td> 266.  </td>

    <td> Special quarantine powers in time of war.  </td>

  </tr>

  <tr>

    <td> 267.  </td>

    <td> Quarantine stations, grounds, and anchorages.  </td>

  </tr>

  <tr>

    <td> 268.  </td>

    <td> Quarantine duties of consular and other officers.  </td>

  </tr>

  <tr>

    <td> 269.  </td>

    <td> Bills of health.  </td>

  </tr>

  <tr>

    <td> 270.  </td>

    <td> Quarantine regulations governing civil air navigation and civil aircraft.  </td>

  </tr>

  <tr>

    <td> 271.  </td>

    <td> Penalties for violation of quarantine laws.  </td>

  </tr>

  <tr>

    <td> 272.  </td>

    <td> Administration of oaths by quarantine officers.  </td>

  </tr>

  <tr>

    <td> 

Part H—Organ Transplants  </td>

  </tr>

  <tr>

    <td> 273.  </td>

    <td> Organ procurement organizations.  </td>

  </tr>

  <tr>

    <td> 273a.  </td>

    <td> National living donor mechanisms.  </td>

  </tr>

  <tr>

    <td> 273b.  </td>

    <td> Report on the long-term health effects of living organ donation.  </td>

  </tr>

  <tr>

    <td> 274.  </td>

    <td> Organ procurement and transplantation network.  </td>

  </tr>

  <tr>

    <td> 274a.  </td>

    <td> Scientific registry.  </td>

  </tr>

  <tr>

    <td> 274b.  </td>

    <td> General provisions respecting grants and contracts.  </td>

  </tr>

  <tr>

    <td> 274c.  </td>

    <td> Administration.  </td>

  </tr>

  <tr>

    <td> 274d.  </td>

    <td> Report.  </td>

  </tr>

  <tr>

    <td> 274e.  </td>

    <td> Prohibition of organ purchases.  </td>

  </tr>

  <tr>

    <td> 274f.  </td>

    <td> Reimbursement of travel and subsistence expenses incurred toward living organ donation.  </td>

  </tr>

  <tr>

    <td> 274f–1.  </td>

    <td> Public awareness; studies and demonstrations.  </td>

  </tr>

  <tr>

    <td> 274f–2.  </td>

    <td> Grants regarding hospital organ donation coordinators.  </td>

  </tr>

  <tr>

    <td> 274f–3.  </td>

    <td> Studies relating to organ donation and the recovery, preservation, and transportation of organs.  </td>

  </tr>

  <tr>

    <td> 274f–4.  </td>

    <td> Report relating to organ donation and the recovery, preservation, and transportation of organs.  </td>

  </tr>

  <tr>

    <td> 274g.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 

Part H–1—Stephanie Tubbs Jones Gift of Life Medal  </td>

  </tr>

  <tr>

    <td> 274i.  </td>

    <td> Eligibility requirements for Stephanie Tubbs Jones Gift of Life Medal.  </td>

  </tr>

  <tr>

    <td> 274i–1.  </td>

    <td> Solicitation of donations; prohibition on use of Federal funds.  </td>

  </tr>

  <tr>

    <td> 274i–2.  </td>

    <td> Design and production of medal.  </td>

  </tr>

  <tr>

    <td> 274i–3.  </td>

    <td> Medals not treated as valuable consideration.  </td>

  </tr>

  <tr>

    <td> 274i–4.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 

Part I—C.W. Bill Young Cell Transplantation Program  </td>

  </tr>

  <tr>

    <td> 274k.  </td>

    <td> National Program.  </td>

  </tr>

  <tr>

    <td> 274l.  </td>

    <td> Stem cell therapeutic outcomes database.  </td>

  </tr>

  <tr>

    <td> 274l–1.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 274m.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 275 to 280a–1.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 

Part J—Prevention and Control of Injuries  </td>

  </tr>

  <tr>

    <td> 280b.  </td>

    <td> Research.  </td>

  </tr>

  <tr>

    <td> 280b–1.  </td>

    <td> Prevention and control activities.  </td>

  </tr>

  <tr>

    <td> 280b–1a.  </td>

    <td> Interpersonal violence within families and among acquaintances.  </td>

  </tr>

  <tr>

    <td> 280b–1b.  </td>

    <td> Use of allotments for rape prevention education.  </td>

  </tr>

  <tr>

    <td> 280b–1c.  </td>

    <td> Prevention of traumatic brain injury.  </td>

  </tr>

  <tr>

    <td> 280b–1d.  </td>

    <td> National program for traumatic brain injury surveillance and registries.  </td>

  </tr>

  <tr>

    <td> 280b–1e.  </td>

    <td> Study on traumatic brain injury.  </td>

  </tr>

  <tr>

    <td> 280b–1f.  </td>

    <td> Prevention of falls among older adults.  </td>

  </tr>

  <tr>

    <td> 280b–2.  </td>

    <td> General provisions.  </td>

  </tr>

  <tr>

    <td> 280b–3.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 280b–4.  </td>

    <td> Study conducted by the Centers for Disease Control and Prevention.  </td>

  </tr>

  <tr>

    <td> 

Part K—Health Care Services in the Home  </td>

  </tr>

  <tr>

    <td> 

subpart i—grants for demonstration projects  </td>

  </tr>

  <tr>

    <td> 280c.  </td>

    <td> Establishment of program.  </td>

  </tr>

  <tr>

    <td> 280c–1.  </td>

    <td> Limitation on duration of grant and requirement of matching funds.  </td>

  </tr>

  <tr>

    <td> 280c–2.  </td>

    <td> General provisions.  </td>

  </tr>

  <tr>

    <td> 

subpart ii—grants for demonstration projects with respect to alzheimer’s disease  </td>

  </tr>

  <tr>

    <td> 280c–3.  </td>

    <td> Establishment of program.  </td>

  </tr>

  <tr>

    <td> 280c–4.  </td>

    <td> Requirement of matching funds.  </td>

  </tr>

  <tr>

    <td> 280c–5.  </td>

    <td> General provisions.  </td>

  </tr>

  <tr>

    <td> 

subpart iii—grants for home visiting services for at-risk families  </td>

  </tr>

  <tr>

    <td> 280c–6.  </td>

    <td> Projects to improve maternal, infant, and child health.  </td>

  </tr>

  <tr>

    <td> 

Part L—[Repealed]  </td>

  </tr>

  <tr>

    <td> 280d.  </td>

    <td> Transferred.  </td>

  </tr>

  <tr>

    <td> 280d–11.  </td>

    <td> Transferred.  </td>

  </tr>

  <tr>

    <td> 

Part M—National Program of Cancer Registries  </td>

  </tr>

  <tr>

    <td> 280e.  </td>

    <td> National program of cancer registries.  </td>

  </tr>

  <tr>

    <td> 280e–1.  </td>

    <td> Planning grants regarding registries.  </td>

  </tr>

  <tr>

    <td> 280e–2.  </td>

    <td> Technical assistance in operations of statewide cancer registries.  </td>

  </tr>

  <tr>

    <td> 280e–3.  </td>

    <td> Study in certain States to determine factors contributing to elevated breast cancer mortality rates.  </td>

  </tr>

  <tr>

    <td> 280e–3a.  </td>

    <td> National childhood cancer registry.  </td>

  </tr>

  <tr>

    <td> 280e–4.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 

Part N—National Foundation for the Centers for Disease Control and Prevention  </td>

  </tr>

  <tr>

    <td> 280e–11.  </td>

    <td> Establishment and duties of Foundation.  </td>

  </tr>

  <tr>

    <td> 

Part O—Fetal Alcohol Syndrome Prevention and Services Program  </td>

  </tr>

  <tr>

    <td> 280f to 280f–3. Omitted.  </td>

  </tr>

  <tr>

    <td> 

Part P—Additional Programs  </td>

  </tr>

  <tr>

    <td> 280g.  </td>

    <td> Children’s asthma treatment grants program.  </td>

  </tr>

  <tr>

    <td> 280g–1.  </td>

    <td> Early detection, diagnosis, and treatment regarding hearing loss in newborns and infants.  </td>

  </tr>

  <tr>

    <td> 280g–2.  </td>

    <td> Childhood malignancies.  </td>

  </tr>

  <tr>

    <td> 280g–3.  </td>

    <td> .Controlled substance monitoring program.  </td>

  </tr>

  <tr>

    <td> 280g–4.  </td>

    <td> Grants to strengthen the healthcare system’s response to domestic violence, dating violence, sexual assault, and stalking.  </td>

  </tr>

  <tr>

    <td> 280g–5.  </td>

    <td> Public and health care provider education and support services.  </td>

  </tr>

  <tr>

    <td> 280g–6.  </td>

    <td> Chronic kidney disease initiatives.  </td>

  </tr>

  <tr>

    <td> 280g–7.  </td>

    <td> Amyotrophic lateral sclerosis registry.  </td>

  </tr>

  <tr>

    <td> 280g–8.  </td>

    <td> Support for patients receiving a positive diagnosis of Down syndrome or other prenatally or postnatally diagnosed conditions.  </td>

  </tr>

  <tr>

    <td> 280g–9.  </td>

    <td> Programs to improve quality of life for persons with paralysis and other physical disabilities.  </td>

  </tr>

  <tr>

    <td> 280g–10.  </td>

    <td> Community Preventive Services Task Force.  </td>

  </tr>

  <tr>

    <td> 280g–11.  </td>

    <td> Grants to promote positive health behaviors and outcomes.  </td>

  </tr>

  <tr>

    <td> 280g–12.  </td>

    <td> Primary Care Extension Program.  </td>

  </tr>

  <tr>

    <td> 280g–13.  </td>

    <td> National Congenital Heart Disease Surveillance System.  </td>

  </tr>

  <tr>

    <td> 280g–14.  </td>

    <td> National diabetes prevention program.  </td>

  </tr>

  <tr>

    <td> 280g–15.  </td>

    <td> State demonstration programs to evaluate alternatives to current medical tort litigation.  </td>

  </tr>

  <tr>

    <td> 280g–16.  </td>

    <td> Food Safety Integrated Centers of Excellence.  </td>

  </tr>

  <tr>

    <td> 

Part Q—Programs To Improve the Health of Children  </td>

  </tr>

  <tr>

    <td> 280h.  </td>

    <td> Grants to promote childhood nutrition and physical activity.  </td>

  </tr>

  <tr>

    <td> 280h–1.  </td>

    <td> Applied research program.  </td>

  </tr>

  <tr>

    <td> 280h–2.  </td>

    <td> Education campaign.  </td>

  </tr>

  <tr>

    <td> 280h–3.  </td>

    <td> Health professional education and training.  </td>

  </tr>

  <tr>

    <td> 280h–4.  </td>

    <td> Grants for the establishment of school-based health centers.  </td>

  </tr>

  <tr>

    <td> 280h–5.  </td>

    <td> School-based health centers.  </td>

  </tr>

  <tr>

    <td> 

Part R—Programs Relating to Autism  </td>

  </tr>

  <tr>

    <td> 280i.  </td>

    <td> Developmental disabilities surveillance and research program.  </td>

  </tr>

  <tr>

    <td> 280i–1.  </td>

    <td> Autism education, early detection, and intervention.  </td>

  </tr>

  <tr>

    <td> 280i–2.  </td>

    <td> Interagency Autism Coordinating Committee.  </td>

  </tr>

  <tr>

    <td> 280i–3.  </td>

    <td> Report to Congress.  </td>

  </tr>

  <tr>

    <td> 280i–4.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 

Part S—Health Care Quality Programs  </td>

  </tr>

  <tr>

    <td> 

subpart i—national strategy for quality improvement in health care  </td>

  </tr>

  <tr>

    <td> 280j.  </td>

    <td> National strategy for quality improvement in health care.  </td>

  </tr>

  <tr>

    <td> 280j–1.  </td>

    <td> Collection and analysis of data for quality and resource use measures.  </td>

  </tr>

  <tr>

    <td> 280j–2.  </td>

    <td> Public reporting of performance information.  </td>

  </tr>

  <tr>

    <td> 280j–3.  </td>

    <td> Quality improvement program for hospitals with a high severity adjusted readmission rate.  </td>

  </tr>

  <tr>

    <td> 

Part T—Oral Healthcare Prevention Activities  </td>

  </tr>

  <tr>

    <td> 280k.  </td>

    <td> Oral healthcare prevention education campaign.  </td>

  </tr>

  <tr>

    <td> 280k–1.  </td>

    <td> Research-based dental caries disease management.  </td>

  </tr>

  <tr>

    <td> 280k–2.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 280k–3.  </td>

    <td> Updating national oral healthcare surveillance activities.  </td>

  </tr>

  <tr>

    <td> 

Part U—Employer-Based Wellness Program  </td>

  </tr>

  <tr>

    <td> 280l.  </td>

    <td> Technical assistance for employer-based wellness programs.  </td>

  </tr>

  <tr>

    <td> 280l–1.  </td>

    <td> National worksite health policies and programs study.  </td>

  </tr>

  <tr>

    <td> 280l–2.  </td>

    <td> Prioritization of evaluation by Secretary.  </td>

  </tr>

  <tr>

    <td> 280l–3.  </td>

    <td> Prohibition of Federal workplace wellness requirements.  </td>

  </tr>

  <tr>

    <td> 

Part V—Programs Relating to Breast Health and Cancer  </td>

  </tr>

  <tr>

    <td> 280m.  </td>

    <td> Young women’s breast health awareness and support of young women diagnosed with breast cancer.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER III—NATIONAL RESEARCH INSTITUTES  </td>

  </tr>

  <tr>

    <td> 

Part A—National Institutes of Health  </td>

  </tr>

  <tr>

    <td> 281.  </td>

    <td> Organization of National Institutes of Health.  </td>

  </tr>

  <tr>

    <td> 282.  </td>

    <td> Director of National Institutes of Health.  </td>

  </tr>

  <tr>

    <td> 282a.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 282b.  </td>

    <td> Electronic coding of grants and activities.  </td>

  </tr>

  <tr>

    <td> 282c.  </td>

    <td> Public access to funded investigators’ final manuscripts.  </td>

  </tr>

  <tr>

    <td> 282d.  </td>

    <td> Transferred.  </td>

  </tr>

  <tr>

    <td> 283.  </td>

    <td> Biennial reports of Director of NIH.  </td>

  </tr>

  <tr>

    <td> 283a.  </td>

    <td> Annual reporting to increase interagency collaboration and coordination.  </td>

  </tr>

  <tr>

    <td> 283a–1.  </td>

    <td> Annual reporting to prevent fraud and abuse.  </td>

  </tr>

  <tr>

    <td> 283a–2.  </td>

    <td> Annual reporting regarding training of graduate students for doctoral degrees.  </td>

  </tr>

  <tr>

    <td> 283a–3.  </td>

    <td> Establishment of program regarding DES.  </td>

  </tr>

  <tr>

    <td> 283b.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 283c.  </td>

    <td> Office of Behavioral and Social Sciences Research.  </td>

  </tr>

  <tr>

    <td> 283d.  </td>

    <td> Children’s Vaccine Initiative.  </td>

  </tr>

  <tr>

    <td> 283e.  </td>

    <td> Plan for use of animals in research.  </td>

  </tr>

  <tr>

    <td> 283f.  </td>

    <td> Requirements regarding surveys of sexual behavior.  </td>

  </tr>

  <tr>

    <td> 283g.  </td>

    <td> Muscular dystrophy; initiative through Director of National Institutes of Health.  </td>

  </tr>

  <tr>

    <td> 283h, 283i.  </td>

    <td> Transferred.  </td>

  </tr>

  <tr>

    <td> 283j.  </td>

    <td> Review of centers of excellence.  </td>

  </tr>

  <tr>

    <td> 283k.  </td>

    <td> Biomedical and behavioral research facilities.  </td>

  </tr>

  <tr>

    <td> 283l.  </td>

    <td> Construction of regional centers for research on primates.  </td>

  </tr>

  <tr>

    <td> 283m.  </td>

    <td> Sanctuary system for surplus chimpanzees.  </td>

  </tr>

  <tr>

    <td> 283n.  </td>

    <td> Shared Instrumentation Grant Program.  </td>

  </tr>

  <tr>

    <td> 

Part B—General Provisions Respecting National Research Institutes  </td>

  </tr>

  <tr>

    <td> 284.  </td>

    <td> Directors of national research institutes.  </td>

  </tr>

  <tr>

    <td> 284a.  </td>

    <td> Advisory councils.  </td>

  </tr>

  <tr>

    <td> 284b.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 284c.  </td>

    <td> Certain uses of funds.  </td>

  </tr>

  <tr>

    <td> 284d.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 284e.  </td>

    <td> Research on osteoporosis, Paget’s disease, and related bone disorders.  </td>

  </tr>

  <tr>

    <td> 284f.  </td>

    <td> Parkinson’s disease.  </td>

  </tr>

  <tr>

    <td> 284g.  </td>

    <td> Expansion, intensification, and coordination of activities of National Institutes of Health with respect to research on autism spectrum disorder.  </td>

  </tr>

  <tr>

    <td> 284h.  </td>

    <td> Pediatric Research Initiative.  </td>

  </tr>

  <tr>

    <td> 284i.  </td>

    <td> Autoimmune diseases.  </td>

  </tr>

  <tr>

    <td> 284j.  </td>

    <td> Muscular dystrophy research.  </td>

  </tr>

  <tr>

    <td> 284k.  </td>

    <td> Clinical research.  </td>

  </tr>

  <tr>

    <td> 284l.  </td>

    <td> Enhancement awards.  </td>

  </tr>

  <tr>

    <td> 284m.  </td>

    <td> Program for pediatric studies of drugs.  </td>

  </tr>

  <tr>

    <td> 284m–1.  </td>

    <td> Pediatric Advisory Committee.  </td>

  </tr>

  <tr>

    <td> 284n.  </td>

    <td> Certain demonstration projects.  </td>

  </tr>

  <tr>

    <td> 284o.  </td>

    <td> Activities of the National Institutes of Health with respect to research on paralysis.  </td>

  </tr>

  <tr>

    <td> 284p.  </td>

    <td> Activities of the National Institutes of Health with respect to research with implications for enhancing daily function for persons with paralysis.  </td>

  </tr>

  <tr>

    <td> 284q.  </td>

    <td> Pain research.  </td>

  </tr>

  <tr>

    <td> 

Part C—Specific Provisions Respecting National Research Institutes  </td>

  </tr>

  <tr>

    <td> 

subpart 1—national cancer institute  </td>

  </tr>

  <tr>

    <td> 285.  </td>

    <td> Purpose of Institute.  </td>

  </tr>

  <tr>

    <td> 285a.  </td>

    <td> National Cancer Program.  </td>

  </tr>

  <tr>

    <td> 285a–1.  </td>

    <td> Cancer control programs.  </td>

  </tr>

  <tr>

    <td> 285a–2.  </td>

    <td> Special authorities of Director.  </td>

  </tr>

  <tr>

    <td> 285a–3.  </td>

    <td> National cancer research and demonstration centers.  </td>

  </tr>

  <tr>

    <td> 285a–4.  </td>

    <td> President’s Cancer Panel; establishment, membership, etc., functions.  </td>

  </tr>

  <tr>

    <td> 285a–5.  </td>

    <td> Associate Director for Prevention; appointment; function.  </td>

  </tr>

  <tr>

    <td> 285a–6.  </td>

    <td> Breast and gynecological cancers.  </td>

  </tr>

  <tr>

    <td> 285a–7.  </td>

    <td> Prostate cancer.  </td>

  </tr>

  <tr>

    <td> 285a–8.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 285a–9.  </td>

    <td> Grants for education, prevention, and early detection of radiogenic cancers and diseases.  </td>

  </tr>

  <tr>

    <td> 285a–10.  </td>

    <td> Research, information, and education with respect to blood cancer.  </td>

  </tr>

  <tr>

    <td> 285a–11.  </td>

    <td> Pediatric cancer research and awareness.  </td>

  </tr>

  <tr>

    <td> 285a–12.  </td>

    <td> Interagency Breast Cancer and Environmental Research Coordinating Committee.  </td>

  </tr>

  <tr>

    <td> 285a–13.  </td>

    <td> Scientific framework for recalcitrant cancers.  </td>

  </tr>

  <tr>

    <td> 

subpart 2—national heart, lung, and blood institute  </td>

  </tr>

  <tr>

    <td> 285b.  </td>

    <td> Purpose of Institute.  </td>

  </tr>

  <tr>

    <td> 285b–1.  </td>

    <td> Heart, blood vessel, lung, and blood disease prevention and control programs.  </td>

  </tr>

  <tr>

    <td> 285b–2.  </td>

    <td> Information and education.  </td>

  </tr>

  <tr>

    <td> 285b–3.  </td>

    <td> National Heart, Blood Vessel, Lung, and Blood Diseases and Blood Resources Program; administrative provisions.  </td>

  </tr>

  <tr>

    <td> 285b–4.  </td>

    <td> National research and demonstration centers.  </td>

  </tr>

  <tr>

    <td> 285b–5.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 285b–6.  </td>

    <td> Associate Director for Prevention; appointment; function.  </td>

  </tr>

  <tr>

    <td> 285b–7.  </td>

    <td> National Center on Sleep Disorders Research.  </td>

  </tr>

  <tr>

    <td> 285b–7a.  </td>

    <td> Heart attack, stroke, and other cardiovascular diseases in women.  </td>

  </tr>

  <tr>

    <td> 285b–7b.  </td>

    <td> Coordination of Federal asthma activities.  </td>

  </tr>

  <tr>

    <td> 285b–7c.  </td>

    <td> Tuberculosis.  </td>

  </tr>

  <tr>

    <td> 285b–8.  </td>

    <td> Congenital heart disease.  </td>

  </tr>

  <tr>

    <td> 

subpart 3—national institute of diabetes and digestive and kidney diseases  </td>

  </tr>

  <tr>

    <td> 285c.  </td>

    <td> Purpose of Institute.  </td>

  </tr>

  <tr>

    <td> 285c–1.  </td>

    <td> Data systems and information clearinghouses.  </td>

  </tr>

  <tr>

    <td> 285c–2.  </td>

    <td> Division Directors for Diabetes, Endocrinology, and Metabolic Diseases, Digestive Diseases and Nutrition, and Kidney, Urologic, and Hematologic Diseases; functions.  </td>

  </tr>

  <tr>

    <td> 285c–3.  </td>

    <td> Interagency coordinating committees.  </td>

  </tr>

  <tr>

    <td> 285c–4.  </td>

    <td> Advisory boards.  </td>

  </tr>

  <tr>

    <td> 285c–5.  </td>

    <td> Research and training centers; development or expansion.  </td>

  </tr>

  <tr>

    <td> 285c–6.  </td>

    <td> Advisory council subcommittees.  </td>

  </tr>

  <tr>

    <td> 285c–7.  </td>

    <td> Biennial report.  </td>

  </tr>

  <tr>

    <td> 285c–8.  </td>

    <td> Nutritional disorders program.  </td>

  </tr>

  <tr>

    <td> 285c–9.  </td>

    <td> Juvenile diabetes.  </td>

  </tr>

  <tr>

    <td> 

subpart 4—national institute of arthritis and musculoskeletal and skin diseases  </td>

  </tr>

  <tr>

    <td> 285d.  </td>

    <td> Purpose of Institute.  </td>

  </tr>

  <tr>

    <td> 285d–1.  </td>

    <td> National arthritis and musculoskeletal and skin diseases program.  </td>

  </tr>

  <tr>

    <td> 285d–2.  </td>

    <td> Research and training.  </td>

  </tr>

  <tr>

    <td> 285d–3.  </td>

    <td> Data system and information clearinghouse.  </td>

  </tr>

  <tr>

    <td> 285d–4.  </td>

    <td> Interagency coordinating committees.  </td>

  </tr>

  <tr>

    <td> 285d–5.  </td>

    <td> Arthritis and musculoskeletal diseases demonstration projects.  </td>

  </tr>

  <tr>

    <td> 285d–6.  </td>

    <td> Multipurpose arthritis and musculoskeletal diseases centers.  </td>

  </tr>

  <tr>

    <td> 285d–6a.  </td>

    <td> Lupus.  </td>

  </tr>

  <tr>

    <td> 285d–7.  </td>

    <td> Advisory Board.  </td>

  </tr>

  <tr>

    <td> 285d–8.  </td>

    <td> Juvenile arthritis and related conditions.  </td>

  </tr>

  <tr>

    <td> 

subpart 5—national institute on aging  </td>

  </tr>

  <tr>

    <td> 285e.  </td>

    <td> Purpose of Institute.  </td>

  </tr>

  <tr>

    <td> 285e–1.  </td>

    <td> Special functions.  </td>

  </tr>

  <tr>

    <td> 285e–2.  </td>

    <td> Alzheimer’s Disease centers.  </td>

  </tr>

  <tr>

    <td> 285e–3.  </td>

    <td> Claude D. Pepper Older Americans Independence Centers.  </td>

  </tr>

  <tr>

    <td> 285e–4.  </td>

    <td> Awards for leadership and excellence in Alzheimer’s disease and related dementias.  </td>

  </tr>

  <tr>

    <td> 285e–5.  </td>

    <td> Research relevant to appropriate services for individuals with Alzheimer’s disease and related dementias and their families.  </td>

  </tr>

  <tr>

    <td> 285e–6.  </td>

    <td> Dissemination of research results.  </td>

  </tr>

  <tr>

    <td> 285e–7.  </td>

    <td> Clearinghouse on Alzheimer’s Disease.  </td>

  </tr>

  <tr>

    <td> 285e–8.  </td>

    <td> Dissemination project.  </td>

  </tr>

  <tr>

    <td> 285e–9.  </td>

    <td> Alzheimer’s disease registry.  </td>

  </tr>

  <tr>

    <td> 285e–10.  </td>

    <td> Aging processes regarding women.  </td>

  </tr>

  <tr>

    <td> 285e–10a.  </td>

    <td> Alzheimer’s clinical research and training awards.  </td>

  </tr>

  <tr>

    <td> 285e–11.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 

subpart 6—national institute of allergy and infectious diseases  </td>

  </tr>

  <tr>

    <td> 285f.  </td>

    <td> Purpose of Institute.  </td>

  </tr>

  <tr>

    <td> 285f–1.  </td>

    <td> Research centers regarding chronic fatigue syndrome.  </td>

  </tr>

  <tr>

    <td> 285f–2.  </td>

    <td> Research and research training regarding tuberculosis.  </td>

  </tr>

  <tr>

    <td> 285f–3.  </td>

    <td> Sexually transmitted disease clinical research and training awards.  </td>

  </tr>

  <tr>

    <td> 285f–4.  </td>

    <td> Microbicide research and development.  </td>

  </tr>

  <tr>

    <td> 

subpart 7—eunice kennedy shriver national institute of child health and human development  </td>

  </tr>

  <tr>

    <td> 285g.  </td>

    <td> Purpose of Institute.  </td>

  </tr>

  <tr>

    <td> 285g–1.  </td>

    <td> Sudden infant death syndrome research.  </td>

  </tr>

  <tr>

    <td> 285g–2.  </td>

    <td> Research on intellectual disabilities.  </td>

  </tr>

  <tr>

    <td> 285g–3.  </td>

    <td> Associate Director for Prevention; appointment; function.  </td>

  </tr>

  <tr>

    <td> 285g–4.  </td>

    <td> National Center for Medical Rehabilitation Research.  </td>

  </tr>

  <tr>

    <td> 285g–5.  </td>

    <td> Research centers with respect to contraception and infertility.  </td>

  </tr>

  <tr>

    <td> 285g–6.  </td>

    <td> Program regarding obstetrics and gynecology.  </td>

  </tr>

  <tr>

    <td> 285g–7.  </td>

    <td> Child health research centers.  </td>

  </tr>

  <tr>

    <td> 285g–8.  </td>

    <td> Prospective longitudinal study on adolescent health.  </td>

  </tr>

  <tr>

    <td> 285g–9.  </td>

    <td> Fragile X.  </td>

  </tr>

  <tr>

    <td> 285g–10.  </td>

    <td> Investment in tomorrow’s pediatric researchers.  </td>

  </tr>

  <tr>

    <td> 

subpart 8—national institute of dental research  </td>

  </tr>

  <tr>

    <td> 285h.  </td>

    <td> Purpose of Institute.  </td>

  </tr>

  <tr>

    <td> 

subpart 9—national eye institute  </td>

  </tr>

  <tr>

    <td> 285i.  </td>

    <td> Purpose of Institute.  </td>

  </tr>

  <tr>

    <td> 285i–1.  </td>

    <td> Clinical research on eye care and diabetes.  </td>

  </tr>

  <tr>

    <td> 

subpart 10—national institute of neurological disorders and stroke  </td>

  </tr>

  <tr>

    <td> 285j.  </td>

    <td> Purpose of Institute.  </td>

  </tr>

  <tr>

    <td> 285j–1.  </td>

    <td> Spinal cord regeneration research.  </td>

  </tr>

  <tr>

    <td> 285j–2.  </td>

    <td> Bioengineering research.  </td>

  </tr>

  <tr>

    <td> 285j–3.  </td>

    <td> Research on multiple sclerosis.  </td>

  </tr>

  <tr>

    <td> 

subpart 11—national institute of general medical sciences  </td>

  </tr>

  <tr>

    <td> 285k.  </td>

    <td> National Institute of General Medical Sciences.  </td>

  </tr>

  <tr>

    <td> 

subpart 12—national institute of environmental health sciences  </td>

  </tr>

  <tr>

    <td> 285l.  </td>

    <td> Purpose of Institute.  </td>

  </tr>

  <tr>

    <td> 285l–1.  </td>

    <td> Applied Toxicological Research and Testing Program.  </td>

  </tr>

  <tr>

    <td> 285l–2.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 285l–3.  </td>

    <td> Interagency Coordinating Committee on the Validation of Alternative Methods.  </td>

  </tr>

  <tr>

    <td> 285l–4.  </td>

    <td> Federal agency action.  </td>

  </tr>

  <tr>

    <td> 285l–5.  </td>

    <td> Application.  </td>

  </tr>

  <tr>

    <td> 285l–6.  </td>

    <td> Methods of controlling certain insect and vermin populations.  </td>

  </tr>

  <tr>

    <td> 

subpart 13—national institute on deafness and other communication disorders  </td>

  </tr>

  <tr>

    <td> 285m.  </td>

    <td> Purpose of Institute.  </td>

  </tr>

  <tr>

    <td> 285m–1.  </td>

    <td> National Deafness and Other Communication Disorders Program.  </td>

  </tr>

  <tr>

    <td> 285m–2.  </td>

    <td> Data System and Information Clearinghouse.  </td>

  </tr>

  <tr>

    <td> 285m–3.  </td>

    <td> Multipurpose deafness and other communication disorders center.  </td>

  </tr>

  <tr>

    <td> 285m–4.  </td>

    <td> National Institute on Deafness and Other Communication Disorders Advisory Board.  </td>

  </tr>

  <tr>

    <td> 285m–5.  </td>

    <td> Interagency Coordinating Committee.  </td>

  </tr>

  <tr>

    <td> 285m–6.  </td>

    <td> Limitation on administrative expenses.  </td>

  </tr>

  <tr>

    <td> 

subpart 14—national institute on alcohol abuse and alcoholism  </td>

  </tr>

  <tr>

    <td> 285n.  </td>

    <td> Purpose of Institute.  </td>

  </tr>

  <tr>

    <td> 285n–1.  </td>

    <td> Associate Director for Prevention.  </td>

  </tr>

  <tr>

    <td> 285n–2.  </td>

    <td> National Alcohol Research Centers; mandatory grant for research of effects of alcohol on elderly.  </td>

  </tr>

  <tr>

    <td> 

subpart 15—national institute on drug abuse  </td>

  </tr>

  <tr>

    <td> 285o.  </td>

    <td> Purpose of Institute.  </td>

  </tr>

  <tr>

    <td> 285o–1.  </td>

    <td> Associate Director for Prevention.  </td>

  </tr>

  <tr>

    <td> 285o–2.  </td>

    <td> Drug Abuse Research Centers.  </td>

  </tr>

  <tr>

    <td> 285o–3.  </td>

    <td> Office on AIDS.  </td>

  </tr>

  <tr>

    <td> 285o–4.  </td>

    <td> Medication Development Program.  </td>

  </tr>

  <tr>

    <td> 

subpart 16—national institute of mental health  </td>

  </tr>

  <tr>

    <td> 285p.  </td>

    <td> Purpose of Institute.  </td>

  </tr>

  <tr>

    <td> 285p–1.  </td>

    <td> Associate Director for Prevention.  </td>

  </tr>

  <tr>

    <td> 285p–2.  </td>

    <td> Office of Rural Mental Health Research.  </td>

  </tr>

  <tr>

    <td> 285p–3.  </td>

    <td> Office on AIDS.  </td>

  </tr>

  <tr>

    <td> 

subpart 17—national institute of nursing research  </td>

  </tr>

  <tr>

    <td> 285q.  </td>

    <td> Purpose of Institute.  </td>

  </tr>

  <tr>

    <td> 285q–1.  </td>

    <td> Specific authorities.  </td>

  </tr>

  <tr>

    <td> 285q–2.  </td>

    <td> Advisory council.  </td>

  </tr>

  <tr>

    <td> 285q–3.  </td>

    <td> Biennial report.  </td>

  </tr>

  <tr>

    <td> 

subpart 18—national institute of biomedical imaging and bioengineering  </td>

  </tr>

  <tr>

    <td> 285r.  </td>

    <td> Purpose of the Institute.  </td>

  </tr>

  <tr>

    <td> 

subpart 19—national human genome research institute  </td>

  </tr>

  <tr>

    <td> 285s.  </td>

    <td> Purpose of Institute.  </td>

  </tr>

  <tr>

    <td> 

subpart 20—national institute on minority health and health disparities  </td>

  </tr>

  <tr>

    <td> 285t.  </td>

    <td> Purpose of Institute.  </td>

  </tr>

  <tr>

    <td> 285t–1.  </td>

    <td> Centers of excellence for research education and training.  </td>

  </tr>

  <tr>

    <td> 285t–2.  </td>

    <td> Loan repayment program for minority health disparities research.  </td>

  </tr>

  <tr>

    <td> 285t–3.  </td>

    <td> General provisions regarding the Institute.  </td>

  </tr>

  <tr>

    <td> 

Part D—National Library of Medicine  </td>

  </tr>

  <tr>

    <td> 

subpart 1—general provisions  </td>

  </tr>

  <tr>

    <td> 286.  </td>

    <td> National Library of Medicine.  </td>

  </tr>

  <tr>

    <td> 286a.  </td>

    <td> Board of Regents.  </td>

  </tr>

  <tr>

    <td> 286a–1.  </td>

    <td> Library facilities.  </td>

  </tr>

  <tr>

    <td> 286a–2.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 

subpart 2—financial assistance  </td>

  </tr>

  <tr>

    <td> 286b.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 286b–1.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 286b–2.  </td>

    <td> National Medical Libraries Assistance Advisory Board.  </td>

  </tr>

  <tr>

    <td> 286b–3.  </td>

    <td> Grants for training in medical library sciences.  </td>

  </tr>

  <tr>

    <td> 286b–4.  </td>

    <td> Assistance for projects in sciences related to health, for research and development in medical library science, and for development of education technologies.  </td>

  </tr>

  <tr>

    <td> 286b–5.  </td>

    <td> Grants for establishing, expanding, and improving basic resources of medical libraries and related instrumentalities.  </td>

  </tr>

  <tr>

    <td> 286b–6.  </td>

    <td> Grants and contracts for establishment of regional medical libraries.  </td>

  </tr>

  <tr>

    <td> 286b–7.  </td>

    <td> Financial support of biomedical scientific publications.  </td>

  </tr>

  <tr>

    <td> 286b–8.  </td>

    <td> Grant payments, records, and audit.  </td>

  </tr>

  <tr>

    <td> 

subpart 3—national center for biotechnology information  </td>

  </tr>

  <tr>

    <td> 286c.  </td>

    <td> Purpose, establishment, functions, and funding of National Center for Biotechnology Information.  </td>

  </tr>

  <tr>

    <td> 

subpart 4—national information center on health services research and health care technology  </td>

  </tr>

  <tr>

    <td> 286d.  </td>

    <td> National Information Center.  </td>

  </tr>

  <tr>

    <td> 

Part E—Other Agencies of NIH  </td>

  </tr>

  <tr>

    <td> 

subpart 1—national center for advancing translational sciences  </td>

  </tr>

  <tr>

    <td> 287.  </td>

    <td> National Center for Advancing Translational Sciences.  </td>

  </tr>

  <tr>

    <td> 287a.  </td>

    <td> Cures Acceleration Network.  </td>

  </tr>

  <tr>

    <td> 287a–1.  </td>

    <td> Office of Rare Diseases.  </td>

  </tr>

  <tr>

    <td> 287a–2.  </td>

    <td> Rare disease regional centers of excellence.  </td>

  </tr>

  <tr>

    <td> 287a–3, 287a–3a.  </td>

    <td> Transferred.  </td>

  </tr>

  <tr>

    <td> 287a–4.  </td>

    <td> General clinical research centers.  </td>

  </tr>

  <tr>

    <td> 

subpart 2—john e. fogarty international center for advanced study in health sciences  </td>

  </tr>

  <tr>

    <td> 287b.  </td>

    <td> General purpose.  </td>

  </tr>

  <tr>

    <td> 

subpart 3—national center for human genome research  </td>

  </tr>

  <tr>

    <td> 287c.  </td>

    <td> Transferred.  </td>

  </tr>

  <tr>

    <td> 

subpart 4—office of dietary supplements  </td>

  </tr>

  <tr>

    <td> 287c–11.  </td>

    <td> Dietary supplements.  </td>

  </tr>

  <tr>

    <td> 

subpart 5—national center for complementary and alternative medicine  </td>

  </tr>

  <tr>

    <td> 287c–21.  </td>

    <td> Purpose of Center.  </td>

  </tr>

  <tr>

    <td> 

subpart 6—transferred  </td>

  </tr>

  <tr>

    <td> 287c–31 to 287c–34. Transferred.  </td>

  </tr>

  <tr>

    <td> 

Part F—Research on Women’s Health  </td>

  </tr>

  <tr>

    <td> 287d.  </td>

    <td> Office of Research on Women’s Health.  </td>

  </tr>

  <tr>

    <td> 287d–1.  </td>

    <td> National data system and clearinghouse on research on women’s health.  </td>

  </tr>

  <tr>

    <td> 287d–2.  </td>

    <td> Biennial report.  </td>

  </tr>

  <tr>

    <td> 

Part G—Awards and Training  </td>

  </tr>

  <tr>

    <td> 288.  </td>

    <td> Ruth L. Kirschstein National Research Service Awards.  </td>

  </tr>

  <tr>

    <td> 288–1.  </td>

    <td> Loan repayment program for research with respect to acquired immune deficiency syndrome.  </td>

  </tr>

  <tr>

    <td> 288–2.  </td>

    <td> Loan repayment program for research with respect to contraception and infertility.  </td>

  </tr>

  <tr>

    <td> 288–3.  </td>

    <td> Loan repayment program for research generally.  </td>

  </tr>

  <tr>

    <td> 288–4.  </td>

    <td> Undergraduate scholarship program regarding professions needed by National Research Institutes.  </td>

  </tr>

  <tr>

    <td> 288–5.  </td>

    <td> Loan repayment program regarding clinical researchers from disadvantaged backgrounds.  </td>

  </tr>

  <tr>

    <td> 288–5a.  </td>

    <td> Loan repayment program regarding clinical researchers.  </td>

  </tr>

  <tr>

    <td> 288–6.  </td>

    <td> Pediatric research loan repayment program.  </td>

  </tr>

  <tr>

    <td> 288a.  </td>

    <td> Visiting Scientist Awards.  </td>

  </tr>

  <tr>

    <td> 288b.  </td>

    <td> Studies respecting biomedical and behavioral research personnel.  </td>

  </tr>

  <tr>

    <td> 

Part H—General Provisions  </td>

  </tr>

  <tr>

    <td> 289.  </td>

    <td> Institutional review boards; ethics guidance program.  </td>

  </tr>

  <tr>

    <td> 289a.  </td>

    <td> Peer review requirements.  </td>

  </tr>

  <tr>

    <td> 289a–1.  </td>

    <td> Certain provisions regarding review and approval of proposals for research.  </td>

  </tr>

  <tr>

    <td> 289a–2.  </td>

    <td> Inclusion of women and minorities in clinical research.  </td>

  </tr>

  <tr>

    <td> 289b.  </td>

    <td> Office of Research Integrity.  </td>

  </tr>

  <tr>

    <td> 289b–1.  </td>

    <td> Protection against financial conflicts of interest in certain projects of research.  </td>

  </tr>

  <tr>

    <td> 289c.  </td>

    <td> Research on public health emergencies.  </td>

  </tr>

  <tr>

    <td> 289c–1.  </td>

    <td> Collaborative use of certain health services research funds.  </td>

  </tr>

  <tr>

    <td> 289d.  </td>

    <td> Animals in research.  </td>

  </tr>

  <tr>

    <td> 289e.  </td>

    <td> Use of appropriations.  </td>

  </tr>

  <tr>

    <td> 289f.  </td>

    <td> Gifts and donations; memorials.  </td>

  </tr>

  <tr>

    <td> 289g.  </td>

    <td> Fetal research.  </td>

  </tr>

  <tr>

    <td> 289g–1.  </td>

    <td> Research on transplantation of fetal tissue.  </td>

  </tr>

  <tr>

    <td> 289g–2.  </td>

    <td> Prohibitions regarding human fetal tissue.  </td>

  </tr>

  <tr>

    <td> 289g–3.  </td>

    <td> Breast implant research.  </td>

  </tr>

  <tr>

    <td> 289g–4.  </td>

    <td> Support for emergency medicine research.  </td>

  </tr>

  <tr>

    <td> 289h.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 290.  </td>

    <td> National Institutes of Health Management Fund; establishment; advancements; availability; final adjustments of advances.  </td>

  </tr>

  <tr>

    <td> 290a.  </td>

    <td> Victims of fire.  </td>

  </tr>

  <tr>

    <td> 

Part I—Foundation for the National Institutes of Health  </td>

  </tr>

  <tr>

    <td> 290b.  </td>

    <td> Establishment and duties of Foundation.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER III–A—SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION  </td>

  </tr>

  <tr>

    <td> 

Part A—Organization and General Authorities  </td>

  </tr>

  <tr>

    <td> 290aa.  </td>

    <td> Substance Abuse and Mental Health Services Administration.  </td>

  </tr>

  <tr>

    <td> 290aa–1.  </td>

    <td> Advisory councils.  </td>

  </tr>

  <tr>

    <td> 290aa–2.  </td>

    <td> Omitted.  </td>

  </tr>

  <tr>

    <td> 290aa–2a.  </td>

    <td> Report on individuals with co-occurring mental illness and substance abuse disorders.  </td>

  </tr>

  <tr>

    <td> 290aa–3.  </td>

    <td> Peer review.  </td>

  </tr>

  <tr>

    <td> 290aa–3a.  </td>

    <td> Transferred.  </td>

  </tr>

  <tr>

    <td> 290aa–4.  </td>

    <td> Data collection.  </td>

  </tr>

  <tr>

    <td> 290aa–5.  </td>

    <td> Grants for the benefit of homeless individuals.  </td>

  </tr>

  <tr>

    <td> 290aa–5a.  </td>

    <td> Alcohol and drug prevention or treatment services for Indians and Native Alaskans.  </td>

  </tr>

  <tr>

    <td> 290aa–5b.  </td>

    <td> Grants for ecstasy and other club drugs abuse prevention.  </td>

  </tr>

  <tr>

    <td> 290aa–6 to 290aa–14. Transferred or Repealed.  </td>

  </tr>

  <tr>

    <td> 

Part B—Centers and Programs  </td>

  </tr>

  <tr>

    <td> 

subpart 1—center for substance abuse treatment  </td>

  </tr>

  <tr>

    <td> 290bb.  </td>

    <td> Center for Substance Abuse Treatment.  </td>

  </tr>

  <tr>

    <td> 290bb–1.  </td>

    <td> Residential treatment programs for pregnant and postpartum women.  </td>

  </tr>

  <tr>

    <td> 290bb–1a.  </td>

    <td> Transferred.  </td>

  </tr>

  <tr>

    <td> 290bb–2.  </td>

    <td> Priority substance abuse treatment needs of regional and national significance.  </td>

  </tr>

  <tr>

    <td> 290bb–2a.  </td>

    <td> Medical treatment of narcotics addiction; report to Congress.  </td>

  </tr>

  <tr>

    <td> 290bb–3 to 290bb–5.   </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 290bb–6.  </td>

    <td> Action by Center for Substance Abuse Treatment and States concerning military facilities.  </td>

  </tr>

  <tr>

    <td> 290bb–7.  </td>

    <td> Substance abuse treatment services for children and adolescents.  </td>

  </tr>

  <tr>

    <td> 290bb–8.  </td>

    <td> Early intervention services for children and adolescents.  </td>

  </tr>

  <tr>

    <td> 290bb–9.  </td>

    <td> Methamphetamine and amphetamine treatment initiative.  </td>

  </tr>

  <tr>

    <td> 

subpart 2—center for substance abuse prevention  </td>

  </tr>

  <tr>

    <td> 290bb–21.  </td>

    <td> Office for Substance Abuse Prevention.  </td>

  </tr>

  <tr>

    <td> 290bb–22.  </td>

    <td> Priority substance abuse prevention needs of regional and national significance.  </td>

  </tr>

  <tr>

    <td> 290bb–23.  </td>

    <td> Prevention, treatment, and rehabilitation model projects for high risk youth.  </td>

  </tr>

  <tr>

    <td> 290bb–24.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 290bb–25.  </td>

    <td> Grants for services for children of substance abusers.  </td>

  </tr>

  <tr>

    <td> 290bb–25a.  </td>

    <td> Grants for strengthening families.  </td>

  </tr>

  <tr>

    <td> 290bb–25b.  </td>

    <td> Programs to reduce underage drinking.  </td>

  </tr>

  <tr>

    <td> 290bb–25c.  </td>

    <td> Services for individuals with fetal alcohol syndrome.  </td>

  </tr>

  <tr>

    <td> 290bb–25d.  </td>

    <td> Centers of excellence on services for individuals with fetal alcohol syndrome and alcohol-related birth defects and treatment for individuals with such conditions and their families.  </td>

  </tr>

  <tr>

    <td> 290bb–25e.  </td>

    <td> Prevention of methamphetamine and inhalant abuse and addiction.  </td>

  </tr>

  <tr>

    <td> 290bb–25f.  </td>

    <td> Prevention and education programs.  </td>

  </tr>

  <tr>

    <td> 

subpart 3—center for mental health services  </td>

  </tr>

  <tr>

    <td> 290bb–31.  </td>

    <td> Center for Mental Health Services.  </td>

  </tr>

  <tr>

    <td> 290bb–32.  </td>

    <td> Priority mental health needs of regional and national significance.  </td>

  </tr>

  <tr>

    <td> 290bb–33.  </td>

    <td> National centers of excellence for depression.  </td>

  </tr>

  <tr>

    <td> 290bb–34.  </td>

    <td> Youth interagency research, training, and technical assistance centers.  </td>

  </tr>

  <tr>

    <td> 290bb–35.  </td>

    <td> Services for youth offenders.  </td>

  </tr>

  <tr>

    <td> 290bb–36.  </td>

    <td> Youth suicide early intervention and prevention strategies.  </td>

  </tr>

  <tr>

    <td> 290bb–36a.  </td>

    <td> Suicide prevention for youth.  </td>

  </tr>

  <tr>

    <td> 290bb–36b.  </td>

    <td> Mental and behavioral health services on campus.  </td>

  </tr>

  <tr>

    <td> 290bb–37.  </td>

    <td> Grants for emergency mental health centers.  </td>

  </tr>

  <tr>

    <td> 290bb–38.  </td>

    <td> Grants for jail diversion programs.  </td>

  </tr>

  <tr>

    <td> 290bb–39.  </td>

    <td> Improving outcomes for children and adolescents through services integration between child welfare and mental health services.  </td>

  </tr>

  <tr>

    <td> 290bb–40.  </td>

    <td> Grants for the integrated treatment of serious mental illness and co-occurring substance abuse.  </td>

  </tr>

  <tr>

    <td> 290bb–41.  </td>

    <td> Training grants.  </td>

  </tr>

  <tr>

    <td> 290bb–42.  </td>

    <td> Awards for co-locating primary and specialty care in community-based mental health settings.  </td>

  </tr>

  <tr>

    <td> 290cc to 290cc–13. Repealed or Transferred.  </td>

  </tr>

  <tr>

    <td> 

Part C—Projects for Assistance in Transition From Homelessness  </td>

  </tr>

  <tr>

    <td> 290cc–21.  </td>

    <td> Formula grants to States.  </td>

  </tr>

  <tr>

    <td> 290cc–22.  </td>

    <td> Purpose of grants.  </td>

  </tr>

  <tr>

    <td> 290cc–23.  </td>

    <td> Requirement of matching funds.  </td>

  </tr>

  <tr>

    <td> 290cc–24.  </td>

    <td> Determination of amount of allotment.  </td>

  </tr>

  <tr>

    <td> 290cc–25.  </td>

    <td> Conversion to categorical program in event of failure of State regarding expenditure of grants.  </td>

  </tr>

  <tr>

    <td> 290cc–26.  </td>

    <td> Provision of certain information from State.  </td>

  </tr>

  <tr>

    <td> 290cc–27.  </td>

    <td> Description of intended expenditures of grant.  </td>

  </tr>

  <tr>

    <td> 290cc–28.  </td>

    <td> Requirement of reports by States.  </td>

  </tr>

  <tr>

    <td> 290cc–29.  </td>

    <td> Requirement of application.  </td>

  </tr>

  <tr>

    <td> 290cc–30.  </td>

    <td> Technical assistance.  </td>

  </tr>

  <tr>

    <td> 290cc–31.  </td>

    <td> Failure to comply with agreements.  </td>

  </tr>

  <tr>

    <td> 290cc–32.  </td>

    <td> Prohibition against certain false statements.  </td>

  </tr>

  <tr>

    <td> 290cc–33.  </td>

    <td> Nondiscrimination.  </td>

  </tr>

  <tr>

    <td> 290cc–34.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 290cc–35.  </td>

    <td> Funding.  </td>

  </tr>

  <tr>

    <td> 

Part D—Miscellaneous Provisions Relating to Substance Abuse and Mental Health  </td>

  </tr>

  <tr>

    <td> 290dd.  </td>

    <td> Substance abuse among government and other employees.  </td>

  </tr>

  <tr>

    <td> 290dd–1.  </td>

    <td> Admission of substance abusers to private and public hospitals and outpatient facilities.  </td>

  </tr>

  <tr>

    <td> 290dd–2.  </td>

    <td> Confidentiality of records.  </td>

  </tr>

  <tr>

    <td> 290dd–3 to 290ee–3. Omitted.  </td>

  </tr>

  <tr>

    <td> 

Part E—Children With Serious Emotional Disturbances  </td>

  </tr>

  <tr>

    <td> 290ff.  </td>

    <td> Comprehensive community mental health services for children with serious emotional disturbances.  </td>

  </tr>

  <tr>

    <td> 290ff–1.  </td>

    <td> Requirements with respect to carrying out purpose of grants.  </td>

  </tr>

  <tr>

    <td> 290ff–2.  </td>

    <td> Individualized plan for services.  </td>

  </tr>

  <tr>

    <td> 290ff–3.  </td>

    <td> Additional provisions.  </td>

  </tr>

  <tr>

    <td> 290ff–4.  </td>

    <td> General provisions.  </td>

  </tr>

  <tr>

    <td> 

Part F—Model Comprehensive Program for Treatment of Substance Abuse  </td>

  </tr>

  <tr>

    <td> 290gg.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 

Part G—Projects for Children and Violence  </td>

  </tr>

  <tr>

    <td> 290hh.  </td>

    <td> Children and violence.  </td>

  </tr>

  <tr>

    <td> 290hh–1.  </td>

    <td> Grants to address the problems of persons who experience violence related stress.  </td>

  </tr>

  <tr>

    <td> 

Part H—Requirement Relating to the Rights of Residents of Certain Facilities  </td>

  </tr>

  <tr>

    <td> 290ii.  </td>

    <td> Requirement relating to the rights of residents of certain facilities.  </td>

  </tr>

  <tr>

    <td> 290ii–1.  </td>

    <td> Reporting requirement.  </td>

  </tr>

  <tr>

    <td> 290ii–2.  </td>

    <td> Regulations and enforcement.  </td>

  </tr>

  <tr>

    <td> 

Part I—Requirement Relating to the Rights of Residents of Certain Non-Medical, Community-Based Facilities for Children and Youth  </td>

  </tr>

  <tr>

    <td> 290jj.  </td>

    <td> Requirement relating to the rights of residents of certain non-medical, community-based facilities for children and youth.  </td>

  </tr>

  <tr>

    <td> 290jj–1.  </td>

    <td> Reporting requirement.  </td>

  </tr>

  <tr>

    <td> 290jj–2.  </td>

    <td> Regulations and enforcement.  </td>

  </tr>

  <tr>

    <td> 

Part J—Services Provided Through Religious Organizations  </td>

  </tr>

  <tr>

    <td> 290kk.  </td>

    <td> Applicability to designated programs.  </td>

  </tr>

  <tr>

    <td> 290kk–1.  </td>

    <td> Religious organizations as program participants.  </td>

  </tr>

  <tr>

    <td> 290kk–2.  </td>

    <td> Limitations on use of funds for certain purposes.  </td>

  </tr>

  <tr>

    <td> 290kk–3.  </td>

    <td> Educational requirements for personnel in drug treatment programs.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER IV—CONSTRUCTION AND MODERNIZATION OF HOSPITALS AND OTHER MEDICAL FACILITIES  </td>

  </tr>

  <tr>

    <td> 291.  </td>

    <td> Congressional declaration of purpose.  </td>

  </tr>

  <tr>

    <td> 

Part A—Grants and Loans for Construction and Modernization of Hospitals and Other Medical Facilities  </td>

  </tr>

  <tr>

    <td> 291a.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 291b.  </td>

    <td> State allotments.  </td>

  </tr>

  <tr>

    <td> 291c.  </td>

    <td> General regulations.  </td>

  </tr>

  <tr>

    <td> 291d.  </td>

    <td> State plans.  </td>

  </tr>

  <tr>

    <td> 291e.  </td>

    <td> Projects for construction or modernization.  </td>

  </tr>

  <tr>

    <td> 291f.  </td>

    <td> Payments for construction or modernization.  </td>

  </tr>

  <tr>

    <td> 291g.  </td>

    <td> Withholding of payments; noncompliance with requirements.  </td>

  </tr>

  <tr>

    <td> 291h.  </td>

    <td> Judicial review.  </td>

  </tr>

  <tr>

    <td> 291i.  </td>

    <td> Recovery of expenditures under certain conditions.  </td>

  </tr>

  <tr>

    <td> 291j.  </td>

    <td> Loans.  </td>

  </tr>

  <tr>

    <td> 

Part B—Loan Guarantees and Loans for Modernization and Construction of Hospitals and Other Medical Facilities  </td>

  </tr>

  <tr>

    <td> 291j–1.  </td>

    <td> Loan guarantees and loans.  </td>

  </tr>

  <tr>

    <td> 291j–2.  </td>

    <td> Allocation among States.  </td>

  </tr>

  <tr>

    <td> 291j–3.  </td>

    <td> Applications and conditions.  </td>

  </tr>

  <tr>

    <td> 291j–4.  </td>

    <td> Payment of interest on guaranteed loans.  </td>

  </tr>

  <tr>

    <td> 291j–5.  </td>

    <td> Limitation on amounts of loans guaranteed or directly made.  </td>

  </tr>

  <tr>

    <td> 291j–6.  </td>

    <td> Loan guarantee and loan fund.  </td>

  </tr>

  <tr>

    <td> 291j–7.  </td>

    <td> Loans to public facilities.  </td>

  </tr>

  <tr>

    <td> 

Part C—Construction or Modernization of Emergency Rooms  </td>

  </tr>

  <tr>

    <td> 291j–8.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 291j–9.  </td>

    <td> Eligibility for grants.  </td>

  </tr>

  <tr>

    <td> 291j–10.  </td>

    <td> Payments.  </td>

  </tr>

  <tr>

    <td> 

Part D—General Provisions  </td>

  </tr>

  <tr>

    <td> 291k.  </td>

    <td> Federal Hospital Council.  </td>

  </tr>

  <tr>

    <td> 291l.  </td>

    <td> Conference of State agencies.  </td>

  </tr>

  <tr>

    <td> 291m.  </td>

    <td> State control of operations.  </td>

  </tr>

  <tr>

    <td> 291m–1.  </td>

    <td> Loans for certain hospital experimentation projects.  </td>

  </tr>

  <tr>

    <td> 291n, 291n–1.  </td>

    <td> Repealed or Omitted.  </td>

  </tr>

  <tr>

    <td> 291o.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 291o–1.  </td>

    <td> Financial statements.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER V—HEALTH PROFESSIONS EDUCATION  </td>

  </tr>

  <tr>

    <td> 

Part A—Student Loans  </td>

  </tr>

  <tr>

    <td> 

subpart i–insured health education assistance loans to graduate students  </td>

  </tr>

  <tr>

    <td> 292.  </td>

    <td> Statement of purpose.  </td>

  </tr>

  <tr>

    <td> 292a.  </td>

    <td> Scope and duration of loan insurance program.  </td>

  </tr>

  <tr>

    <td> 292b.  </td>

    <td> Limitations on individual insured loans and on loan insurance.  </td>

  </tr>

  <tr>

    <td> 292c.  </td>

    <td> Sources of funds.  </td>

  </tr>

  <tr>

    <td> 292d.  </td>

    <td> Eligibility of borrowers and terms of insured loans.  </td>

  </tr>

  <tr>

    <td> 292e.  </td>

    <td> Certificate of loan insurance; effective date of insurance.  </td>

  </tr>

  <tr>

    <td> 292f.  </td>

    <td> Default of borrower.  </td>

  </tr>

  <tr>

    <td> 292g.  </td>

    <td> Risk-based premiums.  </td>

  </tr>

  <tr>

    <td> 292h.  </td>

    <td> Office for Health Education Assistance Loan Default Reduction.  </td>

  </tr>

  <tr>

    <td> 292i.  </td>

    <td> Insurance account.  </td>

  </tr>

  <tr>

    <td> 292j.  </td>

    <td> Powers and responsibilities of Secretary.  </td>

  </tr>

  <tr>

    <td> 292k.  </td>

    <td> Participation by Federal credit unions in Federal, State, and private student loan insurance programs.  </td>

  </tr>

  <tr>

    <td> 292l.  </td>

    <td> Determination of eligible students.  </td>

  </tr>

  <tr>

    <td> 292m.  </td>

    <td> Repayment by Secretary of loans of deceased or disabled borrowers.  </td>

  </tr>

  <tr>

    <td> 292n.  </td>

    <td> Additional requirements for institutions and lenders.  </td>

  </tr>

  <tr>

    <td> 292o.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 292p.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 

subpart ii—federally-supported student loan funds  </td>

  </tr>

  <tr>

    <td> 292q.  </td>

    <td> Agreements for operation of school loan funds.  </td>

  </tr>

  <tr>

    <td> 292r.  </td>

    <td> Loan provisions.  </td>

  </tr>

  <tr>

    <td> 292s.  </td>

    <td> Medical schools and primary health care.  </td>

  </tr>

  <tr>

    <td> 292t.  </td>

    <td> Individuals from disadvantaged backgrounds.  </td>

  </tr>

  <tr>

    <td> 292u.  </td>

    <td> Administrative provisions.  </td>

  </tr>

  <tr>

    <td> 292v.  </td>

    <td> Provision by schools of information to students.  </td>

  </tr>

  <tr>

    <td> 292w.  </td>

    <td> Procedures for appeal of termination of agreements.  </td>

  </tr>

  <tr>

    <td> 292x.  </td>

    <td> Distribution of assets from loan funds.  </td>

  </tr>

  <tr>

    <td> 292y.  </td>

    <td> General provisions.  </td>

  </tr>

  <tr>

    <td> 

Part B—Health Professions Training for Diversity  </td>

  </tr>

  <tr>

    <td> 293.  </td>

    <td> Centers of excellence.  </td>

  </tr>

  <tr>

    <td> 293a.  </td>

    <td> Scholarships for disadvantaged students.  </td>

  </tr>

  <tr>

    <td> 293b.  </td>

    <td> Loan repayments and fellowships regarding faculty positions.  </td>

  </tr>

  <tr>

    <td> 293c.  </td>

    <td> Educational assistance in the health professions regarding individuals from disadvantaged backgrounds.  </td>

  </tr>

  <tr>

    <td> 293d.  </td>

    <td> Authorization of appropriation.  </td>

  </tr>

  <tr>

    <td> 293e.  </td>

    <td> Grants for health professions education.  </td>

  </tr>

  <tr>

    <td> 

Part C—Training in Family Medicine, General Internal Medicine, General Pediatrics, Physician Assistants, General Dentistry, and Pediatric Dentistry  </td>

  </tr>

  <tr>

    <td> 

subpart 1—medical training generally  </td>

  </tr>

  <tr>

    <td> 293j.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 293k.  </td>

    <td> Primary care training and enhancement.  </td>

  </tr>

  <tr>

    <td> 293k–1.  </td>

    <td> Training opportunities for direct care workers.  </td>

  </tr>

  <tr>

    <td> 293k–2.  </td>

    <td> Training in general, pediatric, and public health dentistry.  </td>

  </tr>

  <tr>

    <td> 293l.  </td>

    <td> Advisory Committee on Training in Primary Care Medicine and Dentistry.  </td>

  </tr>

  <tr>

    <td> 293l–1.  </td>

    <td> Teaching health centers development grants.  </td>

  </tr>

  <tr>

    <td> 

subpart 2—training in underserved communities  </td>

  </tr>

  <tr>

    <td> 293m.  </td>

    <td> Rural physician training grants.  </td>

  </tr>

  <tr>

    <td> 293n to 293p.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 

Part D—Interdisciplinary, Community-Based Linkages  </td>

  </tr>

  <tr>

    <td> 294.  </td>

    <td> General provisions.  </td>

  </tr>

  <tr>

    <td> 294a.  </td>

    <td> Area health education centers.  </td>

  </tr>

  <tr>

    <td> 294b.  </td>

    <td> Continuing educational support for health professionals serving in underserved communities.  </td>

  </tr>

  <tr>

    <td> 294c.  </td>

    <td> Education and training relating to geriatrics.  </td>

  </tr>

  <tr>

    <td> 294d.  </td>

    <td> Quentin N. Burdick program for rural interdisciplinary training.  </td>

  </tr>

  <tr>

    <td> 294e.  </td>

    <td> Allied health and other disciplines.  </td>

  </tr>

  <tr>

    <td> 294e–1.  </td>

    <td> Mental and behavioral health education and training grants.  </td>

  </tr>

  <tr>

    <td> 294f.  </td>

    <td> Advisory Committee on Interdisciplinary, Community-Based Linkages.  </td>

  </tr>

  <tr>

    <td> 294g, 294h.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 294i.  </td>

    <td> Program for education and training in pain care.  </td>

  </tr>

  <tr>

    <td> 294j.  </td>

    <td> Demonstration program to integrate quality improvement and patient safety training into clinical education of health professionals.  </td>

  </tr>

  <tr>

    <td> 

Part E—Health Professions and Public Health Workforce  </td>

  </tr>

  <tr>

    <td> 

subpart 1—health professions workforce information and analysis  </td>

  </tr>

  <tr>

    <td> 294n.  </td>

    <td> Health professions workforce information and analysis.  </td>

  </tr>

  <tr>

    <td> 294o.  </td>

    <td> Advisory Council on Graduate Medical Education.  </td>

  </tr>

  <tr>

    <td> 294p.  </td>

    <td> Pediatric rheumatology.  </td>

  </tr>

  <tr>

    <td> 294q.  </td>

    <td> National Health Care Workforce Commission.  </td>

  </tr>

  <tr>

    <td> 294r.  </td>

    <td> State health care workforce development grants.  </td>

  </tr>

  <tr>

    <td> 

subpart 2—public health workforce  </td>

  </tr>

  <tr>

    <td> 295.  </td>

    <td> General provisions.  </td>

  </tr>

  <tr>

    <td> 295a.  </td>

    <td> Public health training centers.  </td>

  </tr>

  <tr>

    <td> 295b.  </td>

    <td> Public health traineeships.  </td>

  </tr>

  <tr>

    <td> 295c.  </td>

    <td> Preventive medicine and public health training grant program.  </td>

  </tr>

  <tr>

    <td> 295d.  </td>

    <td> Health administration traineeships and special projects.  </td>

  </tr>

  <tr>

    <td> 295e.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 

subpart 3—recruitment and retention programs  </td>

  </tr>

  <tr>

    <td> 295f.  </td>

    <td> Investment in tomorrow’s pediatric health care workforce.  </td>

  </tr>

  <tr>

    <td> 295f–1.  </td>

    <td> Public Health Workforce Loan Repayment Program.  </td>

  </tr>

  <tr>

    <td> 295f–2.  </td>

    <td> Training for mid-career public and allied health professionals.  </td>

  </tr>

  <tr>

    <td> 295f–3.  </td>

    <td> Fellowship training in applied public health epidemiology, public health laboratory science, public health informatics, and expansion of the Epidemic Intelligence Service.  </td>

  </tr>

  <tr>

    <td> 

Part F—General Provisions  </td>

  </tr>

  <tr>

    <td> 295j.  </td>

    <td> Preferences and required information in certain programs.  </td>

  </tr>

  <tr>

    <td> 295k.  </td>

    <td> Health professions data.  </td>

  </tr>

  <tr>

    <td> 295l.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 295m.  </td>

    <td> Prohibition against discrimination on basis of sex.  </td>

  </tr>

  <tr>

    <td> 295n.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 295n–1.  </td>

    <td> Application.  </td>

  </tr>

  <tr>

    <td> 295n–2.  </td>

    <td> Use of funds.  </td>

  </tr>

  <tr>

    <td> 295o.  </td>

    <td> Matching requirement.  </td>

  </tr>

  <tr>

    <td> 295o–1.  </td>

    <td> Generally applicable provisions.  </td>

  </tr>

  <tr>

    <td> 295o–2.  </td>

    <td> Technical assistance.  </td>

  </tr>

  <tr>

    <td> 295p.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER VI—NURSING WORKFORCE DEVELOPMENT  </td>

  </tr>

  <tr>

    <td> 

Part A—General Provisions  </td>

  </tr>

  <tr>

    <td> 296.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 296a.  </td>

    <td> Application.  </td>

  </tr>

  <tr>

    <td> 296b.  </td>

    <td> Use of funds.  </td>

  </tr>

  <tr>

    <td> 296c.  </td>

    <td> Matching requirement.  </td>

  </tr>

  <tr>

    <td> 296d.  </td>

    <td> Preference.  </td>

  </tr>

  <tr>

    <td> 296e.  </td>

    <td> Generally applicable provisions.  </td>

  </tr>

  <tr>

    <td> 296e–1.  </td>

    <td> Grants for health professions education.  </td>

  </tr>

  <tr>

    <td> 296f.  </td>

    <td> Technical assistance.  </td>

  </tr>

  <tr>

    <td> 296g.  </td>

    <td> Prohibition against discrimination by schools on basis of sex.  </td>

  </tr>

  <tr>

    <td> 

Part B—Nurse Practitioners, Nurse Midwives, Nurse Anesthetists, and Other Advanced Education Nurses  </td>

  </tr>

  <tr>

    <td> 296j.  </td>

    <td> Advanced education nursing grants.  </td>

  </tr>

  <tr>

    <td> 296j–1.  </td>

    <td> Demonstration grants for family nurse practitioner training programs.  </td>

  </tr>

  <tr>

    <td> 

Part C—Increasing Nursing Workforce Diversity  </td>

  </tr>

  <tr>

    <td> 296m.  </td>

    <td> Workforce diversity grants.  </td>

  </tr>

  <tr>

    <td> 

Part D—Strengthening Capacity for Basic Nurse Education and Practice  </td>

  </tr>

  <tr>

    <td> 296p.  </td>

    <td> Nurse education, practice, and quality grants.  </td>

  </tr>

  <tr>

    <td> 296p–1.  </td>

    <td> Nurse retention grants.  </td>

  </tr>

  <tr>

    <td> 

Part E—Student Loans  </td>

  </tr>

  <tr>

    <td> 297a.  </td>

    <td> Student loan fund.  </td>

  </tr>

  <tr>

    <td> 297b.  </td>

    <td> Loan provisions.  </td>

  </tr>

  <tr>

    <td> 297c, 297c–1.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 297d.  </td>

    <td> Allotments and payments of Federal capital contributions.  </td>

  </tr>

  <tr>

    <td> 297e.  </td>

    <td> Distribution of assets from loan funds.  </td>

  </tr>

  <tr>

    <td> 297f.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 297g.  </td>

    <td> Modification of agreements; compromise, waiver or release.  </td>

  </tr>

  <tr>

    <td> 297h.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 297i.  </td>

    <td> Procedures for appeal of terminations.  </td>

  </tr>

  <tr>

    <td> 297n.  </td>

    <td> Loan repayment and scholarship programs.  </td>

  </tr>

  <tr>

    <td> 297n–1.  </td>

    <td> Nurse faculty loan program.  </td>

  </tr>

  <tr>

    <td> 297o.  </td>

    <td> Eligible individual student loan repayment.  </td>

  </tr>

  <tr>

    <td> 

Part F—National Advisory Council on Nurse Education and Practice  </td>

  </tr>

  <tr>

    <td> 297t.  </td>

    <td> National Advisory Council on Nurse Education and Practice.  </td>

  </tr>

  <tr>

    <td> 

Part G—Public Service Announcements  </td>

  </tr>

  <tr>

    <td> 297w.  </td>

    <td> Public service announcements.  </td>

  </tr>

  <tr>

    <td> 297x.  </td>

    <td> State and local public service announcements.  </td>

  </tr>

  <tr>

    <td> 

Part H—Comprehensive Geriatric Education  </td>

  </tr>

  <tr>

    <td> 298.  </td>

    <td> Comprehensive geriatric education.  </td>

  </tr>

  <tr>

    <td> 

Part I—Funding  </td>

  </tr>

  <tr>

    <td> 298d.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER VII—AGENCY FOR HEALTHCARE RESEARCH AND QUALITY  </td>

  </tr>

  <tr>

    <td> 

Part A—Establishment and General Duties  </td>

  </tr>

  <tr>

    <td> 299.  </td>

    <td> Mission and duties.  </td>

  </tr>

  <tr>

    <td> 299a.  </td>

    <td> General authorities.  </td>

  </tr>

  <tr>

    <td> 299a–1.  </td>

    <td> Research on health disparities.  </td>

  </tr>

  <tr>

    <td> 

Part B—Health Care Improvement Research  </td>

  </tr>

  <tr>

    <td> 299b.  </td>

    <td> Health care outcome improvement research.  </td>

  </tr>

  <tr>

    <td> 299b–1.  </td>

    <td> Private-public partnerships to improve organization and delivery.  </td>

  </tr>

  <tr>

    <td> 299b–2.  </td>

    <td> Information on quality and cost of care.  </td>

  </tr>

  <tr>

    <td> 299b–3.  </td>

    <td> Information systems for health care improvement.  </td>

  </tr>

  <tr>

    <td> 299b–4.  </td>

    <td> Research supporting primary care and access in underserved areas.  </td>

  </tr>

  <tr>

    <td> 299b–4a.  </td>

    <td> Studies on preventive interventions in primary care for older Americans.  </td>

  </tr>

  <tr>

    <td> 299b–5.  </td>

    <td> Health care practice and technology innovation.  </td>

  </tr>

  <tr>

    <td> 299b–6.  </td>

    <td> Coordination of Federal Government quality improvement efforts.  </td>

  </tr>

  <tr>

    <td> 299b–7.  </td>

    <td> Research on outcomes of health care items and services.  </td>

  </tr>

  <tr>

    <td> 299b–8.  </td>

    <td> Omitted.  </td>

  </tr>

  <tr>

    <td> 

Part C—Patient Safety Improvement  </td>

  </tr>

  <tr>

    <td> 299b–21.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 299b–22.  </td>

    <td> Privilege and confidentiality protections.  </td>

  </tr>

  <tr>

    <td> 299b–23.  </td>

    <td> Network of patient safety databases.  </td>

  </tr>

  <tr>

    <td> 299b–24.  </td>

    <td> Patient safety organization certification and listing.  </td>

  </tr>

  <tr>

    <td> 299b–24a.  </td>

    <td> Activities regarding women’s health.  </td>

  </tr>

  <tr>

    <td> 299b–25.  </td>

    <td> Technical assistance.  </td>

  </tr>

  <tr>

    <td> 299b–26.  </td>

    <td> Severability.  </td>

  </tr>

  <tr>

    <td> 

Part D—Health Care Quality Improvement  </td>

  </tr>

  <tr>

    <td> 

subpart 1—quality measure development  </td>

  </tr>

  <tr>

    <td> 299b–31.  </td>

    <td> Quality measure development.  </td>

  </tr>

  <tr>

    <td> 

subpart 2—health care quality improvement programs  </td>

  </tr>

  <tr>

    <td> 299b–33.  </td>

    <td> Health care delivery system research.  </td>

  </tr>

  <tr>

    <td> 299b–34.  </td>

    <td> Quality improvement technical assistance and implementation.  </td>

  </tr>

  <tr>

    <td> 299b–35.  </td>

    <td> Grants or contracts to implement medication management services in treatment of chronic diseases.  </td>

  </tr>

  <tr>

    <td> 299b–36.  </td>

    <td> Program to facilitate shared decisionmaking.  </td>

  </tr>

  <tr>

    <td> 299b–37.  </td>

    <td> Dissemination and building capacity for research.  </td>

  </tr>

  <tr>

    <td> 

Part E—General Provisions  </td>

  </tr>

  <tr>

    <td> 299c.  </td>

    <td> Advisory Council for Healthcare Research and Quality.  </td>

  </tr>

  <tr>

    <td> 299c–1.  </td>

    <td> Peer review with respect to grants and contracts.  </td>

  </tr>

  <tr>

    <td> 299c–2.  </td>

    <td> Certain provisions with respect to development, collection, and dissemination of data.  </td>

  </tr>

  <tr>

    <td> 299c–3.  </td>

    <td> Dissemination of information.  </td>

  </tr>

  <tr>

    <td> 299c–4.  </td>

    <td> Additional provisions with respect to grants and contracts.  </td>

  </tr>

  <tr>

    <td> 299c–5.  </td>

    <td> Certain administrative authorities.  </td>

  </tr>

  <tr>

    <td> 299c–6.  </td>

    <td> Funding.  </td>

  </tr>

  <tr>

    <td> 299c–7.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER VIII—POPULATION RESEARCH AND VOLUNTARY FAMILY PLANNING PROGRAMS  </td>

  </tr>

  <tr>

    <td> 300.  </td>

    <td> Project grants and contracts for family planning services.  </td>

  </tr>

  <tr>

    <td> 300a.  </td>

    <td> Formula grants to States for family planning services.  </td>

  </tr>

  <tr>

    <td> 300a–1.  </td>

    <td> Training grants and contracts; authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 300a–2.  </td>

    <td> Conduct, etc., of research activities.  </td>

  </tr>

  <tr>

    <td> 300a–3.  </td>

    <td> Informational and educational materials development grants and contracts; authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 300a–4.  </td>

    <td> Grants and contracts.  </td>

  </tr>

  <tr>

    <td> 300a–5.  </td>

    <td> Voluntary participation by individuals; participation not prerequisite for eligibility or receipt of other services and information.  </td>

  </tr>

  <tr>

    <td> 300a–6.  </td>

    <td> Prohibition against funding programs using abortion as family planning method.  </td>

  </tr>

  <tr>

    <td> 300a–6a.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 300a–7.  </td>

    <td> Sterilization or abortion.  </td>

  </tr>

  <tr>

    <td> 300a–8.  </td>

    <td> Penalty for United States, etc., officer or employee coercing or endeavoring to coerce procedure upon beneficiary of Federal program.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER VIII–A—ADOLESCENT PREGNANCIES  </td>

  </tr>

  <tr>

    <td> 

Part A—Grant Program  </td>

  </tr>

  <tr>

    <td> 300a–21 to 300a–29. Repealed or Omitted.  </td>

  </tr>

  <tr>

    <td> 

Part B—Improving Coordination of Federal and State Programs  </td>

  </tr>

  <tr>

    <td> 300a–41.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER IX—GENETIC DISEASES, HEMOPHILIA PROGRAMS, AND SUDDEN INFANT DEATH SYNDROME  </td>

  </tr>

  <tr>

    <td> 

Part A—Genetic Diseases  </td>

  </tr>

  <tr>

    <td> 300b.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 300b–1.  </td>

    <td> Research project grants and contracts.  </td>

  </tr>

  <tr>

    <td> 300b–2.  </td>

    <td> Voluntary participation by individuals.  </td>

  </tr>

  <tr>

    <td> 300b–3.  </td>

    <td> Application; special consideration to prior sickle cell anemia grant recipients.  </td>

  </tr>

  <tr>

    <td> 300b–4.  </td>

    <td> Public Health Service facilities.  </td>

  </tr>

  <tr>

    <td> 300b–5.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 300b–6.  </td>

    <td> Applied technology.  </td>

  </tr>

  <tr>

    <td> 300b–7.  </td>

    <td> Tourette Syndrome.  </td>

  </tr>

  <tr>

    <td> 300b–8.  </td>

    <td> Improved newborn and child screening for heritable disorders.  </td>

  </tr>

  <tr>

    <td> 300b–9.  </td>

    <td> Evaluating the effectiveness of newborn and child screening programs.  </td>

  </tr>

  <tr>

    <td> 300b–10.  </td>

    <td> Advisory Committee on Heritable Disorders in Newborns and Children.  </td>

  </tr>

  <tr>

    <td> 300b–11.  </td>

    <td> Clearinghouse of newborn screening information.  </td>

  </tr>

  <tr>

    <td> 300b–12.  </td>

    <td> Laboratory quality.  </td>

  </tr>

  <tr>

    <td> 300b–13.  </td>

    <td> Interagency Coordinating Committee on Newborn and Child Screening.  </td>

  </tr>

  <tr>

    <td> 300b–14.  </td>

    <td> National contingency plan for newborn screening.  </td>

  </tr>

  <tr>

    <td> 300b–15.  </td>

    <td> Hunter Kelly Research Program.  </td>

  </tr>

  <tr>

    <td> 

Part B—Sudden Infant Death Syndrome  </td>

  </tr>

  <tr>

    <td> 300c–11.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 300c–12.  </td>

    <td> Sudden infant death syndrome research.  </td>

  </tr>

  <tr>

    <td> 

Part C—Hemophilia Programs  </td>

  </tr>

  <tr>

    <td> 300c–21.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 300c–22.  </td>

    <td> Blood-separation centers.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER X—TRAUMA CARE  </td>

  </tr>

  <tr>

    <td> 

Part A—General Authority and Duties of Secretary  </td>

  </tr>

  <tr>

    <td> 300d.  </td>

    <td> Establishment.  </td>

  </tr>

  <tr>

    <td> 300d–1, 300d–2.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 300d–3.  </td>

    <td> Establishment of programs for improving trauma care in rural areas.  </td>

  </tr>

  <tr>

    <td> 300d–4.  </td>

    <td> Emergency medical services.  </td>

  </tr>

  <tr>

    <td> 300d–5.  </td>

    <td> Competitive grants for trauma systems for the improvement of trauma care.  </td>

  </tr>

  <tr>

    <td> 300d–6.  </td>

    <td> Competitive grants for regionalized systems for emergency care response.  </td>

  </tr>

  <tr>

    <td> 

Part B—Formula Grants With Respect to Modifications of State Plans  </td>

  </tr>

  <tr>

    <td> 300d–11.  </td>

    <td> Establishment of program.  </td>

  </tr>

  <tr>

    <td> 300d–12.  </td>

    <td> Requirement of matching funds for fiscal years subsequent to first fiscal year of payments.  </td>

  </tr>

  <tr>

    <td> 300d–13.  </td>

    <td> Requirements with respect to carrying out purpose of allotments.  </td>

  </tr>

  <tr>

    <td> 300d–14.  </td>

    <td> Requirement of submission to Secretary of trauma plan and certain information.  </td>

  </tr>

  <tr>

    <td> 300d–15.  </td>

    <td> Restrictions on use of payments.  </td>

  </tr>

  <tr>

    <td> 300d–16.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 300d–17.  </td>

    <td> Requirement of submission of application containing certain agreements and assurances.  </td>

  </tr>

  <tr>

    <td> 300d–18.  </td>

    <td> Determination of amount of allotment.  </td>

  </tr>

  <tr>

    <td> 300d–19.  </td>

    <td> Failure to comply with agreements.  </td>

  </tr>

  <tr>

    <td> 300d–20.  </td>

    <td> Prohibition against certain false statements.  </td>

  </tr>

  <tr>

    <td> 300d–21.  </td>

    <td> Technical assistance and provision by Secretary of supplies and services in lieu of grant funds.  </td>

  </tr>

  <tr>

    <td> 300d–22.  </td>

    <td> Report by Secretary.  </td>

  </tr>

  <tr>

    <td> 

Part C—General Provisions Regarding Parts A and B  </td>

  </tr>

  <tr>

    <td> 300d–31.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 300d–32.  </td>

    <td> Funding.  </td>

  </tr>

  <tr>

    <td> 300d–33.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 

Part D—Trauma Centers Operating in Areas Severely Affected by Drug-Related Violence  </td>

  </tr>

  <tr>

    <td> 300d–41.  </td>

    <td> Grants for certain trauma centers.  </td>

  </tr>

  <tr>

    <td> 300d–42.  </td>

    <td> Preferences in making grants.  </td>

  </tr>

  <tr>

    <td> 300d–43.  </td>

    <td> Certain agreements.  </td>

  </tr>

  <tr>

    <td> 300d–44.  </td>

    <td> General provisions.  </td>

  </tr>

  <tr>

    <td> 300d–45.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 300d–46.  </td>

    <td> Definition.  </td>

  </tr>

  <tr>

    <td> 

Part E—Miscellaneous Programs  </td>

  </tr>

  <tr>

    <td> 300d–51.  </td>

    <td> Residency training programs in emergency medicine.  </td>

  </tr>

  <tr>

    <td> 300d–52.  </td>

    <td> State grants for projects regarding traumatic brain injury.  </td>

  </tr>

  <tr>

    <td> 300d–53.  </td>

    <td> State grants for protection and advocacy services.  </td>

  </tr>

  <tr>

    <td> 

Part F—Interagency Program for Trauma Research  </td>

  </tr>

  <tr>

    <td> 300d–61.  </td>

    <td> Establishment of Program.  </td>

  </tr>

  <tr>

    <td> 

Part G—Poison Control  </td>

  </tr>

  <tr>

    <td> 300d–71.  </td>

    <td> Maintenance of the national toll-free number.  </td>

  </tr>

  <tr>

    <td> 300d–72.  </td>

    <td> Nationwide media campaign to promote poison control center utilization.  </td>

  </tr>

  <tr>

    <td> 300d–73.  </td>

    <td> Maintenance of the poison control center grant program.  </td>

  </tr>

  <tr>

    <td> 300d–74.  </td>

    <td> Rule of construction.  </td>

  </tr>

  <tr>

    <td> 

Part H—Trauma Service Availability  </td>

  </tr>

  <tr>

    <td> 300d–81.  </td>

    <td> Grants to States.  </td>

  </tr>

  <tr>

    <td> 300d–82.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER XI—HEALTH MAINTENANCE ORGANIZATIONS  </td>

  </tr>

  <tr>

    <td> 300e.  </td>

    <td> Requirements of health maintenance organizations.  </td>

  </tr>

  <tr>

    <td> 300e–1.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 300e–2, 300e–3.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 300e–4.  </td>

    <td> Loans and loan guarantees for initial operation costs.  </td>

  </tr>

  <tr>

    <td> 300e–4a.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 300e–5.  </td>

    <td> Application requirements.  </td>

  </tr>

  <tr>

    <td> 300e–6.  </td>

    <td> Administration of assistance programs.  </td>

  </tr>

  <tr>

    <td> 300e–7.  </td>

    <td> General provisions relating to loan guarantees and loans.  </td>

  </tr>

  <tr>

    <td> 300e–8.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 300e–9.  </td>

    <td> Employees’ health benefits plans.  </td>

  </tr>

  <tr>

    <td> 300e–10.  </td>

    <td> Restrictive State laws and practices.  </td>

  </tr>

  <tr>

    <td> 300e–11.  </td>

    <td> Continued regulation of health maintenance organizations.  </td>

  </tr>

  <tr>

    <td> 300e–12.  </td>

    <td> Limitation on source of funding for health maintenance organizations.  </td>

  </tr>

  <tr>

    <td> 300e–13.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 300e–14.  </td>

    <td> Annual report.  </td>

  </tr>

  <tr>

    <td> 300e–14a.  </td>

    <td> Health services for Indians and domestic agricultural migratory and seasonal workers.  </td>

  </tr>

  <tr>

    <td> 300e–15.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 300e–16.  </td>

    <td> Training and technical assistance.  </td>

  </tr>

  <tr>

    <td> 300e–17.  </td>

    <td> Financial disclosure.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER XII—SAFETY OF PUBLIC WATER SYSTEMS  </td>

  </tr>

  <tr>

    <td> 

Part A—Definitions  </td>

  </tr>

  <tr>

    <td> 300f.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 

Part B—Public Water Systems  </td>

  </tr>

  <tr>

    <td> 300g.  </td>

    <td> Coverage.  </td>

  </tr>

  <tr>

    <td> 300g–1.  </td>

    <td> National drinking water regulations.  </td>

  </tr>

  <tr>

    <td> 300g–2.  </td>

    <td> State primary enforcement responsibility.  </td>

  </tr>

  <tr>

    <td> 300g–3.  </td>

    <td> Enforcement of drinking water regulations.  </td>

  </tr>

  <tr>

    <td> 300g–4.  </td>

    <td> Variances.  </td>

  </tr>

  <tr>

    <td> 300g–5.  </td>

    <td> Exemptions.  </td>

  </tr>

  <tr>

    <td> 300g–6.  </td>

    <td> Prohibition on use of lead pipes, solder, and flux.  </td>

  </tr>

  <tr>

    <td> 300g–7.  </td>

    <td> Monitoring of contaminants.  </td>

  </tr>

  <tr>

    <td> 300g–8.  </td>

    <td> Operator certification.  </td>

  </tr>

  <tr>

    <td> 300g–9.  </td>

    <td> Capacity development.  </td>

  </tr>

  <tr>

    <td> 

Part C—Protection of Underground Sources of Drinking Water  </td>

  </tr>

  <tr>

    <td> 300h.  </td>

    <td> Regulations for State programs.  </td>

  </tr>

  <tr>

    <td> 300h–1.  </td>

    <td> State primary enforcement responsibility.  </td>

  </tr>

  <tr>

    <td> 300h–2.  </td>

    <td> Enforcement of program.  </td>

  </tr>

  <tr>

    <td> 300h–3.  </td>

    <td> Interim regulation of underground injections.  </td>

  </tr>

  <tr>

    <td> 300h–4.  </td>

    <td> Optional demonstration by States relating to oil or natural gas.  </td>

  </tr>

  <tr>

    <td> 300h–5.  </td>

    <td> Regulation of State programs.  </td>

  </tr>

  <tr>

    <td> 300h–6.  </td>

    <td> Sole source aquifer demonstration program.  </td>

  </tr>

  <tr>

    <td> 300h–7.  </td>

    <td> State programs to establish wellhead protection areas.  </td>

  </tr>

  <tr>

    <td> 300h–8.  </td>

    <td> State ground water protection grants.  </td>

  </tr>

  <tr>

    <td> 

Part D—Emergency Powers  </td>

  </tr>

  <tr>

    <td> 300i.  </td>

    <td> Emergency powers.  </td>

  </tr>

  <tr>

    <td> 300i–1.  </td>

    <td> Tampering with public water systems.  </td>

  </tr>

  <tr>

    <td> 300i–2.  </td>

    <td> Terrorist and other intentional acts.  </td>

  </tr>

  <tr>

    <td> 300i–3.  </td>

    <td> Contaminant prevention, detection and response.  </td>

  </tr>

  <tr>

    <td> 300i–4.  </td>

    <td> Supply disruption prevention, detection and response.  </td>

  </tr>

  <tr>

    <td> 

Part E—General Provisions  </td>

  </tr>

  <tr>

    <td> 300j.  </td>

    <td> Assurances of availability of adequate supplies of chemicals necessary for treatment of water.  </td>

  </tr>

  <tr>

    <td> 300j–1.  </td>

    <td> Research, technical assistance, information, training of personnel.  </td>

  </tr>

  <tr>

    <td> 300j–2.  </td>

    <td> Grants for State programs.  </td>

  </tr>

  <tr>

    <td> 300j–3.  </td>

    <td> Special project grants and guaranteed loans.  </td>

  </tr>

  <tr>

    <td> 300j–3a.  </td>

    <td> Grants to public sector agencies.  </td>

  </tr>

  <tr>

    <td> 300j–3b.  </td>

    <td> Contaminant standards or treatment technique guidelines.  </td>

  </tr>

  <tr>

    <td> 300j–3c.  </td>

    <td> National assistance program for water infrastructure and watersheds.  </td>

  </tr>

  <tr>

    <td> 300j–4.  </td>

    <td> Records and inspections.  </td>

  </tr>

  <tr>

    <td> 300j–5.  </td>

    <td> National Drinking Water Advisory Council.  </td>

  </tr>

  <tr>

    <td> 300j–6.  </td>

    <td> Federal agencies.  </td>

  </tr>

  <tr>

    <td> 300j–7.  </td>

    <td> Judicial review.  </td>

  </tr>

  <tr>

    <td> 300j–8.  </td>

    <td> Citizen’s civil action.  </td>

  </tr>

  <tr>

    <td> 300j–9.  </td>

    <td> General provisions.  </td>

  </tr>

  <tr>

    <td> 300j–10.  </td>

    <td> Appointment of scientific, etc., personnel by Administrator of Environmental Protection Agency for implementation of responsibilities; compensation.  </td>

  </tr>

  <tr>

    <td> 300j–11.  </td>

    <td> Indian Tribes.  </td>

  </tr>

  <tr>

    <td> 300j–12.  </td>

    <td> State revolving loan funds.  </td>

  </tr>

  <tr>

    <td> 300j–13.  </td>

    <td> Source water quality assessment.  </td>

  </tr>

  <tr>

    <td> 300j–14.  </td>

    <td> Source water petition program.  </td>

  </tr>

  <tr>

    <td> 300j–15.  </td>

    <td> Water conservation plan.  </td>

  </tr>

  <tr>

    <td> 300j–16.  </td>

    <td> Assistance to colonias.  </td>

  </tr>

  <tr>

    <td> 300j–17.  </td>

    <td> Estrogenic substances screening program.  </td>

  </tr>

  <tr>

    <td> 300j–18.  </td>

    <td> Drinking water studies.  </td>

  </tr>

  <tr>

    <td> 

Part F—Additional Requirements To Regulate Safety of Drinking Water  </td>

  </tr>

  <tr>

    <td> 300j–21.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 300j–22.  </td>

    <td> Recall of drinking water coolers with lead-lined tanks.  </td>

  </tr>

  <tr>

    <td> 300j–23.  </td>

    <td> Drinking water coolers containing lead.  </td>

  </tr>

  <tr>

    <td> 300j–24.  </td>

    <td> Lead contamination in school drinking water.  </td>

  </tr>

  <tr>

    <td> 300j–25.  </td>

    <td> Federal assistance for State programs regarding lead contamination in school drinking water.  </td>

  </tr>

  <tr>

    <td> 300j–26.  </td>

    <td> Certification of testing laboratories.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER XIII—PREVENTIVE HEALTH MEASURES WITH RESPECT TO BREAST AND CERVICAL CANCERS  </td>

  </tr>

  <tr>

    <td> 300k.  </td>

    <td> Establishment of program of grants to States.  </td>

  </tr>

  <tr>

    <td> 300l.  </td>

    <td> Requirement of matching funds.  </td>

  </tr>

  <tr>

    <td> 300l–1.  </td>

    <td> Requirement regarding medicaid.  </td>

  </tr>

  <tr>

    <td> 300m.  </td>

    <td> Requirements with respect to type and quality of services.  </td>

  </tr>

  <tr>

    <td> 300n.  </td>

    <td> Additional required agreements.  </td>

  </tr>

  <tr>

    <td> 300n–1.  </td>

    <td> Description of intended uses of grant.  </td>

  </tr>

  <tr>

    <td> 300n–2.  </td>

    <td> Requirement of submission of application.  </td>

  </tr>

  <tr>

    <td> 300n–3.  </td>

    <td> Technical assistance and provision of supplies and services in lieu of grant funds.  </td>

  </tr>

  <tr>

    <td> 300n–4.  </td>

    <td> Evaluations and reports.  </td>

  </tr>

  <tr>

    <td> 300n–4a.  </td>

    <td> Supplemental grants for additional preventive health services.  </td>

  </tr>

  <tr>

    <td> 300n–5.  </td>

    <td> Funding for general program.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER XIV—HEALTH RESOURCES DEVELOPMENT  </td>

  </tr>

  <tr>

    <td> 300o to 300p–3.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 

Part A—Loans and Loan Guarantees  </td>

  </tr>

  <tr>

    <td> 300q.  </td>

    <td> Loan and loan guarantee authority.  </td>

  </tr>

  <tr>

    <td> 300q–1.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 300q–2.  </td>

    <td> General provisions.  </td>

  </tr>

  <tr>

    <td> 

Part B—Project Grants  </td>

  </tr>

  <tr>

    <td> 300r.  </td>

    <td> Grants for construction or modernization projects.  </td>

  </tr>

  <tr>

    <td> 

Part C—General Provisions  </td>

  </tr>

  <tr>

    <td> 300s.  </td>

    <td> General regulations.  </td>

  </tr>

  <tr>

    <td> 300s–1.  </td>

    <td> Medical facility project applications.  </td>

  </tr>

  <tr>

    <td> 300s–1a.  </td>

    <td> Recovery of expenditures under certain conditions.  </td>

  </tr>

  <tr>

    <td> 300s–2.  </td>

    <td> State supervision or control of operations of facilities receiving funds.  </td>

  </tr>

  <tr>

    <td> 300s–3.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 300s–4.  </td>

    <td> Reporting and audit requirements for recipients.  </td>

  </tr>

  <tr>

    <td> 300s–5.  </td>

    <td> Availability of technical and other nonfinancial assistance to eligible applicants.  </td>

  </tr>

  <tr>

    <td> 300s–6.  </td>

    <td> Enforcement of assurances.  </td>

  </tr>

  <tr>

    <td> 

Part D—Area Health Services Development Funds  </td>

  </tr>

  <tr>

    <td> 300t.  </td>

    <td> Development grants for health systems agencies.  </td>

  </tr>

  <tr>

    <td> 

Part E—Program To Assist and Encourage Voluntary Discontinuance of Unneeded Hospital Services and Conversion of Unneeded Hospital Services to Other Health Services Needed by Community  </td>

  </tr>

  <tr>

    <td> 300t–11.  </td>

    <td> Grants and assistance for establishment of program.  </td>

  </tr>

  <tr>

    <td> 300t–12.  </td>

    <td> Grants for discontinuance and conversion.  </td>

  </tr>

  <tr>

    <td> 300t–13.  </td>

    <td> Grants to States for reduction of excess hospital capacity.  </td>

  </tr>

  <tr>

    <td> 300t–14.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER XV—HEALTH INFORMATION AND HEALTH PROMOTION  </td>

  </tr>

  <tr>

    <td> 300u.  </td>

    <td> General authority of Secretary.  </td>

  </tr>

  <tr>

    <td> 300u–1.  </td>

    <td> Grants and contracts for research programs; authority of Secretary; review of applications; additional functions; periodic public survey.  </td>

  </tr>

  <tr>

    <td> 300u–2.  </td>

    <td> Grants and contracts for community health programs.  </td>

  </tr>

  <tr>

    <td> 300u–3.  </td>

    <td> Grants and contracts for information programs; authority of Secretary; particular activities.  </td>

  </tr>

  <tr>

    <td> 300u–4.  </td>

    <td> Status reports to President and Congress; study of health education and preventive health services with respect to insurance coverage.  </td>

  </tr>

  <tr>

    <td> 300u–5.  </td>

    <td> Centers for research and demonstration of health promotion and disease prevention.  </td>

  </tr>

  <tr>

    <td> 300u–6.  </td>

    <td> Office of Minority Health.  </td>

  </tr>

  <tr>

    <td> 300u–6a.  </td>

    <td> Individual offices of minority health within the Department.  </td>

  </tr>

  <tr>

    <td> 300u–7.  </td>

    <td> Office of Adolescent Health.  </td>

  </tr>

  <tr>

    <td> 300u–8.  </td>

    <td> Biennial report regarding nutrition and health.  </td>

  </tr>

  <tr>

    <td> 300u–9.  </td>

    <td> Education regarding DES.  </td>

  </tr>

  <tr>

    <td> 300u–10.  </td>

    <td> National Prevention, Health Promotion and Public Health Council.  </td>

  </tr>

  <tr>

    <td> 300u–11.  </td>

    <td> Prevention and Public Health Fund.  </td>

  </tr>

  <tr>

    <td> 300u–12.  </td>

    <td> Education and outreach campaign regarding preventive benefits.  </td>

  </tr>

  <tr>

    <td> 300u–13.  </td>

    <td> Community transformation grants.  </td>

  </tr>

  <tr>

    <td> 300u–14.  </td>

    <td> Healthy aging, living well; evaluation of community-based prevention and wellness programs for Medicare beneficiaries.  </td>

  </tr>

  <tr>

    <td> 300u–15.  </td>

    <td> Research on optimizing the delivery of public health services.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER XVI—PRESIDENT’S COMMISSION FOR THE STUDY OF ETHICAL PROBLEMS IN MEDICINE AND BIOMEDICAL AND BEHAVIOR RESEARCH  </td>

  </tr>

  <tr>

    <td> 300v.  </td>

    <td> Commission.  </td>

  </tr>

  <tr>

    <td> 300v–1.  </td>

    <td> Duties of Commission.  </td>

  </tr>

  <tr>

    <td> 300v–2.  </td>

    <td> Administrative provisions.  </td>

  </tr>

  <tr>

    <td> 300v–3.  </td>

    <td> Authorization of appropriations; termination of Commission.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER XVII—BLOCK GRANTS  </td>

  </tr>

  <tr>

    <td> 

Part A—Preventive Health and Health Services Block Grants  </td>

  </tr>

  <tr>

    <td> 300w.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 300w–1.  </td>

    <td> Allotments.  </td>

  </tr>

  <tr>

    <td> 300w–2.  </td>

    <td> Payments under allotments to States.  </td>

  </tr>

  <tr>

    <td> 300w–3.  </td>

    <td> Use of allotments.  </td>

  </tr>

  <tr>

    <td> 300w–4.  </td>

    <td> Application for payments; State plan.  </td>

  </tr>

  <tr>

    <td> 300w–5.  </td>

    <td> Reports, data, and audits.  </td>

  </tr>

  <tr>

    <td> 300w–6.  </td>

    <td> Withholding of funds.  </td>

  </tr>

  <tr>

    <td> 300w–7.  </td>

    <td> Nondiscrimination provisions.  </td>

  </tr>

  <tr>

    <td> 300w–8.  </td>

    <td> Criminal penalty for false statements.  </td>

  </tr>

  <tr>

    <td> 300w–9.  </td>

    <td> Emergency medical services for children.  </td>

  </tr>

  <tr>

    <td> 300w–10.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 

Part B—Block Grants Regarding Mental Health and Substance Abuse  </td>

  </tr>

  <tr>

    <td> 

subpart i—block grants for community mental health services  </td>

  </tr>

  <tr>

    <td> 300x.  </td>

    <td> Formula grants to States.  </td>

  </tr>

  <tr>

    <td> 300x–1.  </td>

    <td> State plan for comprehensive community mental health services for certain individuals.  </td>

  </tr>

  <tr>

    <td> 300x–2.  </td>

    <td> Certain agreements.  </td>

  </tr>

  <tr>

    <td> 300x–3.  </td>

    <td> State mental health planning council.  </td>

  </tr>

  <tr>

    <td> 300x–4.  </td>

    <td> Additional provisions.  </td>

  </tr>

  <tr>

    <td> 300x–5.  </td>

    <td> Restrictions on use of payments.  </td>

  </tr>

  <tr>

    <td> 300x–6.  </td>

    <td> Application for grant.  </td>

  </tr>

  <tr>

    <td> 300x–7.  </td>

    <td> Determination of amount of allotment.  </td>

  </tr>

  <tr>

    <td> 300x–8.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 300x–9.  </td>

    <td> Funding.  </td>

  </tr>

  <tr>

    <td> 

subpart ii—block grants for prevention and treatment of substance abuse  </td>

  </tr>

  <tr>

    <td> 300x–21.  </td>

    <td> Formula grants to States.  </td>

  </tr>

  <tr>

    <td> 300x–22.  </td>

    <td> Certain allocations.  </td>

  </tr>

  <tr>

    <td> 300x–23.  </td>

    <td> Intravenous substance abuse.  </td>

  </tr>

  <tr>

    <td> 300x–24.  </td>

    <td> Requirements regarding tuberculosis and human immunodeficiency virus.  </td>

  </tr>

  <tr>

    <td> 300x–25.  </td>

    <td> Group homes for recovering substance abusers.  </td>

  </tr>

  <tr>

    <td> 300x–26.  </td>

    <td> State law regarding sale of tobacco products to individuals under age of 18.  </td>

  </tr>

  <tr>

    <td> 300x–26a.  </td>

    <td> Withholding of substance abuse funding under section 300x–26.  </td>

  </tr>

  <tr>

    <td> 300x–27.  </td>

    <td> Treatment services for pregnant women.  </td>

  </tr>

  <tr>

    <td> 300x–28.  </td>

    <td> Additional agreements.  </td>

  </tr>

  <tr>

    <td> 300x–29.  </td>

    <td> Submission to Secretary of statewide assessment of needs.  </td>

  </tr>

  <tr>

    <td> 300x–30.  </td>

    <td> Maintenance of effort regarding State expenditures.  </td>

  </tr>

  <tr>

    <td> 300x–31.  </td>

    <td> Restrictions on expenditure of grant.  </td>

  </tr>

  <tr>

    <td> 300x–32.  </td>

    <td> Application for grant; approval of State plan.  </td>

  </tr>

  <tr>

    <td> 300x–33.  </td>

    <td> Determination of amount of allotment.  </td>

  </tr>

  <tr>

    <td> 300x–34.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 300x–35.  </td>

    <td> Funding.  </td>

  </tr>

  <tr>

    <td> 

subpart iii—general provisions  </td>

  </tr>

  <tr>

    <td> 300x–51.  </td>

    <td> Opportunity for public comment on State plans.  </td>

  </tr>

  <tr>

    <td> 300x–52.  </td>

    <td> Requirement of reports and audits by States.  </td>

  </tr>

  <tr>

    <td> 300x–53.  </td>

    <td> Additional requirements.  </td>

  </tr>

  <tr>

    <td> 300x–54.  </td>

    <td> Disposition of certain funds appropriated for allotments.  </td>

  </tr>

  <tr>

    <td> 300x–55.  </td>

    <td> Failure to comply with agreements.  </td>

  </tr>

  <tr>

    <td> 300x–56.  </td>

    <td> Prohibitions regarding receipt of funds.  </td>

  </tr>

  <tr>

    <td> 300x–57.  </td>

    <td> Nondiscrimination.  </td>

  </tr>

  <tr>

    <td> 300x–58.  </td>

    <td> Technical assistance and provision of supplies and services in lieu of grant funds.  </td>

  </tr>

  <tr>

    <td> 300x–59.  </td>

    <td> Plans for performance partnerships.  </td>

  </tr>

  <tr>

    <td> 300x–60.  </td>

    <td> Rule of construction regarding delegation of authority to States.  </td>

  </tr>

  <tr>

    <td> 300x–61.  </td>

    <td> Solicitation of views of certain entities.  </td>

  </tr>

  <tr>

    <td> 300x–62.  </td>

    <td> Availability to States of grant payments.  </td>

  </tr>

  <tr>

    <td> 300x–63.  </td>

    <td> Continuation of certain programs.  </td>

  </tr>

  <tr>

    <td> 300x–64.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 300x–65.  </td>

    <td> Services provided by nongovernmental organizations.  </td>

  </tr>

  <tr>

    <td> 300x–66.  </td>

    <td> Services for individuals with co-occurring disorders.  </td>

  </tr>

  <tr>

    <td> 

Part C—Certain Programs Regarding Mental Health and Substance Abuse  </td>

  </tr>

  <tr>

    <td> 

subpart i—data infrastructure development  </td>

  </tr>

  <tr>

    <td> 300y.  </td>

    <td> Data infrastructure development.  </td>

  </tr>

  <tr>

    <td> 

subpart ii—interim maintenance treatment of narcotics dependence  </td>

  </tr>

  <tr>

    <td> 300y–11.  </td>

    <td> Interim maintenance treatment.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER XVIII—ADOLESCENT FAMILY LIFE DEMONSTRATION PROJECTS  </td>

  </tr>

  <tr>

    <td> 300z.  </td>

    <td> Findings and purposes.  </td>

  </tr>

  <tr>

    <td> 300z–1.  </td>

    <td> Definitions; regulations applicable.  </td>

  </tr>

  <tr>

    <td> 300z–2.  </td>

    <td> Demonstration projects; grant authorization, etc.  </td>

  </tr>

  <tr>

    <td> 300z–3.  </td>

    <td> Uses of grants for demonstration proj­ects for services.  </td>

  </tr>

  <tr>

    <td> 300z–4.  </td>

    <td> Grants for demonstration projects for services.  </td>

  </tr>

  <tr>

    <td> 300z–5.  </td>

    <td> Requirements for applications.  </td>

  </tr>

  <tr>

    <td> 300z–6.  </td>

    <td> Coordination of programs.  </td>

  </tr>

  <tr>

    <td> 300z–7.  </td>

    <td> Research.  </td>

  </tr>

  <tr>

    <td> 300z–8.  </td>

    <td> Evaluation and administration.  </td>

  </tr>

  <tr>

    <td> 300z–9.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 300z–10.  </td>

    <td> Restrictions.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER XIX—VACCINES  </td>

  </tr>

  <tr>

    <td> 

Part 1—National Vaccine Program  </td>

  </tr>

  <tr>

    <td> 300aa–1.  </td>

    <td> Establishment.  </td>

  </tr>

  <tr>

    <td> 300aa–2.  </td>

    <td> Program responsibilities.  </td>

  </tr>

  <tr>

    <td> 300aa–3.  </td>

    <td> Plan.  </td>

  </tr>

  <tr>

    <td> 300aa–4.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 300aa–5.  </td>

    <td> National Vaccine Advisory Committee.  </td>

  </tr>

  <tr>

    <td> 300aa–6.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 

Part 2—National Vaccine Injury Compensation Program  </td>

  </tr>

  <tr>

    <td> 

subpart a—program requirements  </td>

  </tr>

  <tr>

    <td> 300aa–10.  </td>

    <td> Establishment of program.  </td>

  </tr>

  <tr>

    <td> 300aa–11.  </td>

    <td> Petitions for compensation.  </td>

  </tr>

  <tr>

    <td> 300aa–12.  </td>

    <td> Court jurisdiction.  </td>

  </tr>

  <tr>

    <td> 300aa–13.  </td>

    <td> Determination of eligibility and compensation.  </td>

  </tr>

  <tr>

    <td> 300aa–14.  </td>

    <td> Vaccine Injury Table.  </td>

  </tr>

  <tr>

    <td> 300aa–15.  </td>

    <td> Compensation.  </td>

  </tr>

  <tr>

    <td> 300aa–16.  </td>

    <td> Limitations of actions.  </td>

  </tr>

  <tr>

    <td> 300aa–17.  </td>

    <td> Subrogation.  </td>

  </tr>

  <tr>

    <td> 300aa–18.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 300aa–19.  </td>

    <td> Advisory Commission on Childhood Vaccines.  </td>

  </tr>

  <tr>

    <td> 

subpart b—additional remedies  </td>

  </tr>

  <tr>

    <td> 300aa–21.  </td>

    <td> Authority to bring actions.  </td>

  </tr>

  <tr>

    <td> 300aa–22.  </td>

    <td> Standards of responsibility.  </td>

  </tr>

  <tr>

    <td> 300aa–23.  </td>

    <td> Trial.  </td>

  </tr>

  <tr>

    <td> 

subpart c—assuring a safer childhood vaccination program in united states  </td>

  </tr>

  <tr>

    <td> 300aa–25.  </td>

    <td> Recording and reporting of information.  </td>

  </tr>

  <tr>

    <td> 300aa–26.  </td>

    <td> Vaccine information.  </td>

  </tr>

  <tr>

    <td> 300aa–27.  </td>

    <td> Mandate for safer childhood vaccines.  </td>

  </tr>

  <tr>

    <td> 300aa–28.  </td>

    <td> Manufacturer recordkeeping and reporting.  </td>

  </tr>

  <tr>

    <td> 

subpart d—general provisions  </td>

  </tr>

  <tr>

    <td> 300aa–31.  </td>

    <td> Citizen’s actions.  </td>

  </tr>

  <tr>

    <td> 300aa–32.  </td>

    <td> Judicial review.  </td>

  </tr>

  <tr>

    <td> 300aa–33.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 300aa–34.  </td>

    <td> Termination of program.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER XX—REQUIREMENTS FOR CERTAIN GROUP HEALTH PLANS FOR CERTAIN STATE AND LOCAL EMPLOYEES  </td>

  </tr>

  <tr>

    <td> 300bb–1.  </td>

    <td> State and local governmental group health plans must provide continuation coverage to certain individuals.  </td>

  </tr>

  <tr>

    <td> 300bb–2.  </td>

    <td> Continuation coverage.  </td>

  </tr>

  <tr>

    <td> 300bb–3.  </td>

    <td> Qualifying event.  </td>

  </tr>

  <tr>

    <td> 300bb–4.  </td>

    <td> Applicable premium.  </td>

  </tr>

  <tr>

    <td> 300bb–5.  </td>

    <td> Election.  </td>

  </tr>

  <tr>

    <td> 300bb–6.  </td>

    <td> Notice requirements.  </td>

  </tr>

  <tr>

    <td> 300bb–7.  </td>

    <td> Enforcement.  </td>

  </tr>

  <tr>

    <td> 300bb–8.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER XXI—RESEARCH WITH RESPECT TO ACQUIRED IMMUNE DEFICIENCY SYNDROME  </td>

  </tr>

  <tr>

    <td> 

Part A—Administration of Research Programs  </td>

  </tr>

  <tr>

    <td> 300cc.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 300cc–1.  </td>

    <td> Requirement of expediting awards of grants and contracts for research.  </td>

  </tr>

  <tr>

    <td> 300cc–2.  </td>

    <td> Requirements with respect to processing of requests for personnel and administrative support.  </td>

  </tr>

  <tr>

    <td> 300cc–3.  </td>

    <td> Establishment of Research Advisory Committee.  </td>

  </tr>

  <tr>

    <td> 

Part B—Research Authority  </td>

  </tr>

  <tr>

    <td> 300cc–11.  </td>

    <td> Clinical evaluation units at National Institutes of Health.  </td>

  </tr>

  <tr>

    <td> 300cc–12.  </td>

    <td> Use of investigational new drugs with respect to acquired immune deficiency syndrome.  </td>

  </tr>

  <tr>

    <td> 300cc–13.  </td>

    <td> Terry Beirn Community-Based AIDS Research Initiative.  </td>

  </tr>

  <tr>

    <td> 300cc–14.  </td>

    <td> Evaluation of certain treatments.  </td>

  </tr>

  <tr>

    <td> 300cc–15.  </td>

    <td> Support of international efforts.  </td>

  </tr>

  <tr>

    <td> 300cc–16.  </td>

    <td> Research centers.  </td>

  </tr>

  <tr>

    <td> 300cc–17.  </td>

    <td> Information services.  </td>

  </tr>

  <tr>

    <td> 300cc–18.  </td>

    <td> Development of model protocols for clinical care of infected individuals.  </td>

  </tr>

  <tr>

    <td> 300cc–19.  </td>

    <td> National blood resource education program.  </td>

  </tr>

  <tr>

    <td> 300cc–20.  </td>

    <td> Additional authority with respect to research.  </td>

  </tr>

  <tr>

    <td> 

Part C—Research Training  </td>

  </tr>

  <tr>

    <td> 300cc–31.  </td>

    <td> Fellowships and training.  </td>

  </tr>

  <tr>

    <td> 

Part D—Office of AIDS Research  </td>

  </tr>

  <tr>

    <td> 

subpart i—interagency coordination of activities  </td>

  </tr>

  <tr>

    <td> 300cc–40.  </td>

    <td> Establishment of Office.  </td>

  </tr>

  <tr>

    <td> 300cc–40a.  </td>

    <td> Microbicide research.  </td>

  </tr>

  <tr>

    <td> 300cc–40b.  </td>

    <td> Advisory Council; coordinating committees.  </td>

  </tr>

  <tr>

    <td> 300cc–40c.  </td>

    <td> Comprehensive plan for expenditure of appropriations.  </td>

  </tr>

  <tr>

    <td> 300cc–41.  </td>

    <td> Additional authorities.  </td>

  </tr>

  <tr>

    <td> 

subpart ii—emergency discretionary fund  </td>

  </tr>

  <tr>

    <td> 300cc–43.  </td>

    <td> Emergency Discretionary Fund.  </td>

  </tr>

  <tr>

    <td> 

subpart iii—general provisions  </td>

  </tr>

  <tr>

    <td> 300cc–45.  </td>

    <td> General provisions regarding Office.  </td>

  </tr>

  <tr>

    <td> 

Part E—General Provisions  </td>

  </tr>

  <tr>

    <td> 300cc–51.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER XXII—HEALTH SERVICES WITH RESPECT TO ACQUIRED IMMUNE DEFICIENCY SYNDROME  </td>

  </tr>

  <tr>

    <td> 

Part A—Formula Grants to States for Home and Community-Based Health Services  </td>

  </tr>

  <tr>

    <td> 300dd to 300dd–14. Repealed.  </td>

  </tr>

  <tr>

    <td> 

Part B—Subacute Care  </td>

  </tr>

  <tr>

    <td> 300dd–21.  </td>

    <td> Demonstration projects.  </td>

  </tr>

  <tr>

    <td> 

Part C—Other Health Services  </td>

  </tr>

  <tr>

    <td> 300dd–31.  </td>

    <td> Grants for anonymous testing.  </td>

  </tr>

  <tr>

    <td> 300dd–32.  </td>

    <td> Requirement of provision of certain counseling services.  </td>

  </tr>

  <tr>

    <td> 300dd–33.  </td>

    <td> Funding.  </td>

  </tr>

  <tr>

    <td> 300dd–41.  </td>

    <td> Transferred.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER XXIII—PREVENTION OF ACQUIRED IMMUNE DEFICIENCY SYNDROME  </td>

  </tr>

  <tr>

    <td> 300ee.  </td>

    <td> Use of funds.  </td>

  </tr>

  <tr>

    <td> 300ee–1.  </td>

    <td> Establishment of office with respect to minority health and acquired immune deficiency syndrome.  </td>

  </tr>

  <tr>

    <td> 300ee–2.  </td>

    <td> Information for health and public safety workers.  </td>

  </tr>

  <tr>

    <td> 300ee–3.  </td>

    <td> Continuing education for health care providers.  </td>

  </tr>

  <tr>

    <td> 300ee–4.  </td>

    <td> Technical assistance.  </td>

  </tr>

  <tr>

    <td> 300ee–5.  </td>

    <td> Use of funds to supply hypodermic needles or syringes for illegal drug use; prohibition.  </td>

  </tr>

  <tr>

    <td> 300ee–6.  </td>

    <td> Transferred.  </td>

  </tr>

  <tr>

    <td> 

Part A—Formula Grants to States  </td>

  </tr>

  <tr>

    <td> 300ee–11.  </td>

    <td> Establishment of program.  </td>

  </tr>

  <tr>

    <td> 300ee–12.  </td>

    <td> Provisions with respect to carrying out purpose of grants.  </td>

  </tr>

  <tr>

    <td> 300ee–13.  </td>

    <td> Requirement of submission of application containing certain agreements and assurances.  </td>

  </tr>

  <tr>

    <td> 300ee–14.  </td>

    <td> Restrictions on use of grant.  </td>

  </tr>

  <tr>

    <td> 300ee–15.  </td>

    <td> Requirement of reports and audits by States.  </td>

  </tr>

  <tr>

    <td> 300ee–16.  </td>

    <td> Additional required agreements.  </td>

  </tr>

  <tr>

    <td> 300ee–17.  </td>

    <td> Determination of amount of allotments for States.  </td>

  </tr>

  <tr>

    <td> 300ee–18.  </td>

    <td> Failure to comply with agreements.  </td>

  </tr>

  <tr>

    <td> 300ee–19.  </td>

    <td> Prohibition against certain false statements.  </td>

  </tr>

  <tr>

    <td> 300ee–20.  </td>

    <td> Technical assistance and provision by Secretary of supplies and services in lieu of grant funds.  </td>

  </tr>

  <tr>

    <td> 300ee–21.  </td>

    <td> Evaluations.  </td>

  </tr>

  <tr>

    <td> 300ee–22.  </td>

    <td> Report by Secretary.  </td>

  </tr>

  <tr>

    <td> 300ee–23.  </td>

    <td> Definition.  </td>

  </tr>

  <tr>

    <td> 300ee–24.  </td>

    <td> Funding.  </td>

  </tr>

  <tr>

    <td> 

Part B—National Information Programs  </td>

  </tr>

  <tr>

    <td> 300ee–31.  </td>

    <td> Availability of information to general public.  </td>

  </tr>

  <tr>

    <td> 300ee–32.  </td>

    <td> Public information campaigns.  </td>

  </tr>

  <tr>

    <td> 300ee–33.  </td>

    <td> Provision of information to underserved populations.  </td>

  </tr>

  <tr>

    <td> 300ee–34.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER XXIV—HIV HEALTH CARE SERVICES PROGRAM  </td>

  </tr>

  <tr>

    <td> 300ff.  </td>

    <td> Purpose.  </td>

  </tr>

  <tr>

    <td> 300ff–1.  </td>

    <td> Prohibition on use of funds.  </td>

  </tr>

  <tr>

    <td> 

Part A—Emergency Relief for Areas With Substantial Need for Services  </td>

  </tr>

  <tr>

    <td> 

subpart i—general grant provisions  </td>

  </tr>

  <tr>

    <td> 300ff–11.  </td>

    <td> Establishment of program of grants.  </td>

  </tr>

  <tr>

    <td> 300ff–12.  </td>

    <td> Administration and planning council.  </td>

  </tr>

  <tr>

    <td> 300ff–13.  </td>

    <td> Type and distribution of grants.  </td>

  </tr>

  <tr>

    <td> 300ff–14.  </td>

    <td> Use of amounts.  </td>

  </tr>

  <tr>

    <td> 300ff–15.  </td>

    <td> Application.  </td>

  </tr>

  <tr>

    <td> 300ff–16.  </td>

    <td> Technical assistance.  </td>

  </tr>

  <tr>

    <td> 300ff–17.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 300ff–18.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 

subpart ii—transitional grants  </td>

  </tr>

  <tr>

    <td> 300ff–19.  </td>

    <td> Establishment of program.  </td>

  </tr>

  <tr>

    <td> 

subpart iii—general provisions  </td>

  </tr>

  <tr>

    <td> 300ff–20.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 

Part B—Care Grant Program  </td>

  </tr>

  <tr>

    <td> 

subpart i—general grant provisions  </td>

  </tr>

  <tr>

    <td> 300ff–21.  </td>

    <td> Grants.  </td>

  </tr>

  <tr>

    <td> 300ff–22.  </td>

    <td> General use of grants.  </td>

  </tr>

  <tr>

    <td> 300ff–23.  </td>

    <td> Grants to establish HIV care consortia.  </td>

  </tr>

  <tr>

    <td> 300ff–24.  </td>

    <td> Grants for home- and community-based care.  </td>

  </tr>

  <tr>

    <td> 300ff–25.  </td>

    <td> Continuum of health insurance coverage.  </td>

  </tr>

  <tr>

    <td> 300ff–26.  </td>

    <td> Provision of treatments.  </td>

  </tr>

  <tr>

    <td> 300ff–27.  </td>

    <td> State application.  </td>

  </tr>

  <tr>

    <td> 300ff–27a.  </td>

    <td> Spousal notification.  </td>

  </tr>

  <tr>

    <td> 300ff–28.  </td>

    <td> Distribution of funds.  </td>

  </tr>

  <tr>

    <td> 300ff–29.  </td>

    <td> Technical assistance.  </td>

  </tr>

  <tr>

    <td> 300ff–29a.  </td>

    <td> Supplemental grants.  </td>

  </tr>

  <tr>

    <td> 300ff–30.  </td>

    <td> Emerging communities.  </td>

  </tr>

  <tr>

    <td> 300ff–31.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 300ff–31a.  </td>

    <td> Timeframe for obligation and expenditure of grant funds.  </td>

  </tr>

  <tr>

    <td> 300ff–31b.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 

subpart ii—provisions concerning pregnancy and perinatal transmission of hiv  </td>

  </tr>

  <tr>

    <td> 300ff–33.  </td>

    <td> Early diagnosis grant program.  </td>

  </tr>

  <tr>

    <td> 300ff–34.  </td>

    <td> Perinatal transmission of HIV/AIDS; contingent requirement regarding State grants under this part.  </td>

  </tr>

  <tr>

    <td> 300ff–35, 300ff–36.   </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 300ff–37.  </td>

    <td> State HIV testing programs established prior to or after May 20, 1996.  </td>

  </tr>

  <tr>

    <td> 300ff–37a.  </td>

    <td> Recommendations for reducing incidence of perinatal transmission.  </td>

  </tr>

  <tr>

    <td> 

subpart iii—certain partner notification programs  </td>

  </tr>

  <tr>

    <td> 300ff–38.  </td>

    <td> Grants for partner notification programs.  </td>

  </tr>

  <tr>

    <td> 

Part C—Early Intervention Services  </td>

  </tr>

  <tr>

    <td> 300ff–41 to 300ff–50. Repealed.  </td>

  </tr>

  <tr>

    <td> 

subpart i—categorical grants  </td>

  </tr>

  <tr>

    <td> 300ff–51.  </td>

    <td> Establishment of a program.  </td>

  </tr>

  <tr>

    <td> 300ff–52.  </td>

    <td> Minimum qualifications of grantees.  </td>

  </tr>

  <tr>

    <td> 300ff–53.  </td>

    <td> Preferences in making grants.  </td>

  </tr>

  <tr>

    <td> 300ff–54.  </td>

    <td> Miscellaneous provisions.  </td>

  </tr>

  <tr>

    <td> 300ff–55.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 

subpart ii—general provisions  </td>

  </tr>

  <tr>

    <td> 300ff–61.  </td>

    <td> Confidentiality and informed consent.  </td>

  </tr>

  <tr>

    <td> 300ff–62.  </td>

    <td> Provision of certain counseling services.  </td>

  </tr>

  <tr>

    <td> 300ff–63.  </td>

    <td> Applicability of requirements regarding confidentiality, informed consent, and counseling.  </td>

  </tr>

  <tr>

    <td> 300ff–64.  </td>

    <td> Additional required agreements.  </td>

  </tr>

  <tr>

    <td> 300ff–65.  </td>

    <td> Requirement of submission of application containing certain agreements and assurances.  </td>

  </tr>

  <tr>

    <td> 300ff–66.  </td>

    <td> Provision by Secretary of supplies and services in lieu of grant funds.  </td>

  </tr>

  <tr>

    <td> 300ff–67.  </td>

    <td> Use of funds.  </td>

  </tr>

  <tr>

    <td> 

Part D—Women, Infants, Children, and Youth  </td>

  </tr>

  <tr>

    <td> 300ff–71.  </td>

    <td> Grants for coordinated services and access to research for women, infants, children, and youth.  </td>

  </tr>

  <tr>

    <td> 

Part E—General Provisions  </td>

  </tr>

  <tr>

    <td> 300ff–81.  </td>

    <td> Coordination.  </td>

  </tr>

  <tr>

    <td> 300ff–82.  </td>

    <td> Audits.  </td>

  </tr>

  <tr>

    <td> 300ff–83.  </td>

    <td> Public health emergency.  </td>

  </tr>

  <tr>

    <td> 300ff–84.  </td>

    <td> Prohibition on promotion of certain activities.  </td>

  </tr>

  <tr>

    <td> 300ff–85.  </td>

    <td> Privacy protections.  </td>

  </tr>

  <tr>

    <td> 300ff–86.  </td>

    <td> GAO report.  </td>

  </tr>

  <tr>

    <td> 300ff–87.  </td>

    <td> Severity of need index.  </td>

  </tr>

  <tr>

    <td> 300ff–87a.  </td>

    <td> National HIV/AIDS testing goal.  </td>

  </tr>

  <tr>

    <td> 300ff–88.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 

Part F—Demonstration and Training  </td>

  </tr>

  <tr>

    <td> 

subpart i—special projects of national significance  </td>

  </tr>

  <tr>

    <td> 300ff–101.  </td>

    <td> Special projects of national significance.  </td>

  </tr>

  <tr>

    <td> 

subpart ii—aids education and training centers  </td>

  </tr>

  <tr>

    <td> 300ff–111.  </td>

    <td> HIV/AIDS communities, schools, and centers.  </td>

  </tr>

  <tr>

    <td> 

subpart iii—minority aids initiative  </td>

  </tr>

  <tr>

    <td> 300ff–121.  </td>

    <td> Minority AIDS initiative.  </td>

  </tr>

  <tr>

    <td> 

Part G—Notification of Possible Exposure to Infectious Diseases  </td>

  </tr>

  <tr>

    <td> 300ff–131.  </td>

    <td> Infectious diseases and circumstances relevant to notification requirements.  </td>

  </tr>

  <tr>

    <td> 300ff–132.  </td>

    <td> Routine notifications with respect to airborne infectious diseases in victims assisted.  </td>

  </tr>

  <tr>

    <td> 300ff–133.  </td>

    <td> Request for notification with respect to victims assisted.  </td>

  </tr>

  <tr>

    <td> 300ff–134.  </td>

    <td> Procedures for notification of exposure.  </td>

  </tr>

  <tr>

    <td> 300ff–135.  </td>

    <td> Notification of employee.  </td>

  </tr>

  <tr>

    <td> 300ff–136.  </td>

    <td> Selection of designated officers.  </td>

  </tr>

  <tr>

    <td> 300ff–137.  </td>

    <td> Limitation with respect to duties of medical facilities.  </td>

  </tr>

  <tr>

    <td> 300ff–138.  </td>

    <td> Miscellaneous provisions.  </td>

  </tr>

  <tr>

    <td> 300ff–139.  </td>

    <td> Injunctions regarding violation of prohibition.  </td>

  </tr>

  <tr>

    <td> 300ff–140.  </td>

    <td> Applicability of part.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER XXV—REQUIREMENTS RELATING TO HEALTH INSURANCE COVERAGE  </td>

  </tr>

  <tr>

    <td> 

Part A—Individual and Group Market Reforms  </td>

  </tr>

  <tr>

    <td> 

subpart i—general reform  </td>

  </tr>

  <tr>

    <td> 300gg.  </td>

    <td> Fair health insurance premiums.  </td>

  </tr>

  <tr>

    <td> 300gg–1.  </td>

    <td> Guaranteed availability of coverage.  </td>

  </tr>

  <tr>

    <td> 300gg–2.  </td>

    <td> Guaranteed renewability of coverage.  </td>

  </tr>

  <tr>

    <td> 300gg–3.  </td>

    <td> Prohibition of preexisting condition exclusions or other discrimination based on health status.  </td>

  </tr>

  <tr>

    <td> 300gg–4.  </td>

    <td> Prohibiting discrimination against individual participants and beneficiaries based on health status.  </td>

  </tr>

  <tr>

    <td> 300gg–5.  </td>

    <td> Non-discrimination in health care.  </td>

  </tr>

  <tr>

    <td> 300gg–6.  </td>

    <td> Comprehensive health insurance coverage.  </td>

  </tr>

  <tr>

    <td> 300gg–7.  </td>

    <td> Prohibition on excessive waiting periods.  </td>

  </tr>

  <tr>

    <td> 300gg–8.  </td>

    <td> Coverage for individuals participating in approved clinical trials.  </td>

  </tr>

  <tr>

    <td> 300gg–9.  </td>

    <td> Disclosure of information.  </td>

  </tr>

  <tr>

    <td> 

subpart ii—improving coverage  </td>

  </tr>

  <tr>

    <td> 300gg–11.  </td>

    <td> No lifetime or annual limits.  </td>

  </tr>

  <tr>

    <td> 300gg–12.  </td>

    <td> Prohibition on rescissions.  </td>

  </tr>

  <tr>

    <td> 300gg–13.  </td>

    <td> Coverage of preventive health services.  </td>

  </tr>

  <tr>

    <td> 300gg–14.  </td>

    <td> Extension of dependent coverage.  </td>

  </tr>

  <tr>

    <td> 300gg–15.  </td>

    <td> Development and utilization of uniform explanation of coverage documents and standardized definitions.  </td>

  </tr>

  <tr>

    <td> 300gg–15a.  </td>

    <td> Provision of additional information.  </td>

  </tr>

  <tr>

    <td> 300gg–16.  </td>

    <td> Prohibition on discrimination in favor of highly compensated individuals.  </td>

  </tr>

  <tr>

    <td> 300gg–17.  </td>

    <td> Ensuring the quality of care.  </td>

  </tr>

  <tr>

    <td> 300gg–18.  </td>

    <td> Bringing down the cost of health care coverage.  </td>

  </tr>

  <tr>

    <td> 300gg–19.  </td>

    <td> Appeals process.  </td>

  </tr>

  <tr>

    <td> 300gg–19a.  </td>

    <td> Patient protections.  </td>

  </tr>

  <tr>

    <td> 

subpart 2—exclusion of plans; enforcement; preemption  </td>

  </tr>

  <tr>

    <td> 300gg–21.  </td>

    <td> Exclusion of certain plans.  </td>

  </tr>

  <tr>

    <td> 300gg–22.  </td>

    <td> Enforcement.  </td>

  </tr>

  <tr>

    <td> 300gg–23.  </td>

    <td> Preemption; State flexibility; construction.  </td>

  </tr>

  <tr>

    <td> 300gg–25.  </td>

    <td> Standards relating to benefits for mothers and newborns.  </td>

  </tr>

  <tr>

    <td> 300gg–26.  </td>

    <td> Parity in mental health and substance use disorder benefits.  </td>

  </tr>

  <tr>

    <td> 300gg–27.  </td>

    <td> Required coverage for reconstructive surgery following mastectomies.  </td>

  </tr>

  <tr>

    <td> 300gg–28.  </td>

    <td> Coverage of dependent students on medically necessary leave of absence.  </td>

  </tr>

  <tr>

    <td> 

Part B—Individual Market Rules  </td>

  </tr>

  <tr>

    <td> 

subpart 1—portability, access, and renewability requirements  </td>

  </tr>

  <tr>

    <td> 300gg–41.  </td>

    <td> Guaranteed availability of individual health insurance coverage to certain individuals with prior group coverage.  </td>

  </tr>

  <tr>

    <td> 300gg–42.  </td>

    <td> Guaranteed renewability of individual health insurance coverage.  </td>

  </tr>

  <tr>

    <td> 300gg–43.  </td>

    <td> Certification of coverage.  </td>

  </tr>

  <tr>

    <td> 300gg–44.  </td>

    <td> State flexibility in individual market reforms.  </td>

  </tr>

  <tr>

    <td> 300gg–45.  </td>

    <td> Relief for high risk pools.  </td>

  </tr>

  <tr>

    <td> 

subpart 2—other requirements  </td>

  </tr>

  <tr>

    <td> 300gg–51.  </td>

    <td> Standards relating to benefits for mothers and newborns.  </td>

  </tr>

  <tr>

    <td> 300gg–52.  </td>

    <td> Required coverage for reconstructive surgery following mastectomies.  </td>

  </tr>

  <tr>

    <td> 300gg–53.  </td>

    <td> Prohibition of health discrimination on the basis of genetic information.  </td>

  </tr>

  <tr>

    <td> 300gg–54.  </td>

    <td> Coverage of dependent students on medically necessary leave of absence.  </td>

  </tr>

  <tr>

    <td> 

subpart 3—general provisions  </td>

  </tr>

  <tr>

    <td> 300gg–61.  </td>

    <td> Enforcement.  </td>

  </tr>

  <tr>

    <td> 300gg–62.  </td>

    <td> Preemption and application.  </td>

  </tr>

  <tr>

    <td> 300gg–63.  </td>

    <td> General exceptions.  </td>

  </tr>

  <tr>

    <td> 

Part C—Definitions; Miscellaneous Provisions  </td>

  </tr>

  <tr>

    <td> 300gg–91.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 300gg–92.  </td>

    <td> Regulations.  </td>

  </tr>

  <tr>

    <td> 300gg–93.  </td>

    <td> Health insurance consumer information.  </td>

  </tr>

  <tr>

    <td> 300gg–94.  </td>

    <td> Ensuring that consumers get value for their dollars.  </td>

  </tr>

  <tr>

    <td> 300gg–95.  </td>

    <td> Uniform fraud and abuse referral format.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER XXVI—NATIONAL ALL-HAZARDS PREPAREDNESS FOR PUBLIC HEALTH EMERGENCIES  </td>

  </tr>

  <tr>

    <td> 

Part A—National All-Hazards Preparedness and Response Planning, Coordinating, and Reporting  </td>

  </tr>

  <tr>

    <td> 300hh.  </td>

    <td> Public health and medical preparedness and response functions.  </td>

  </tr>

  <tr>

    <td> 300hh–1.  </td>

    <td> National Health Security Strategy.  </td>

  </tr>

  <tr>

    <td> 300hh–2.  </td>

    <td> Enhancing medical surge capacity.  </td>

  </tr>

  <tr>

    <td> 

Part B—All-Hazards Emergency Preparedness and Response  </td>

  </tr>

  <tr>

    <td> 300hh–10.  </td>

    <td> Coordination of preparedness for and response to all-hazards public health emergencies.  </td>

  </tr>

  <tr>

    <td> 300hh–10a.  </td>

    <td> National Advisory Committee on Children and Disasters.  </td>

  </tr>

  <tr>

    <td> 300hh–11.  </td>

    <td> National Disaster Medical System.  </td>

  </tr>

  <tr>

    <td> 300hh–12.  </td>

    <td> Transferred.  </td>

  </tr>

  <tr>

    <td> 300hh–13.  </td>

    <td> Evaluation of new and emerging technologies regarding bioterrorist attack and other public health emergencies.  </td>

  </tr>

  <tr>

    <td> 300hh–14.  </td>

    <td> Protection of health and safety during disasters.  </td>

  </tr>

  <tr>

    <td> 300hh–15.  </td>

    <td> Volunteer Medical Reserve Corps.  </td>

  </tr>

  <tr>

    <td> 300hh–16.  </td>

    <td> At-risk individuals.  </td>

  </tr>

  <tr>

    <td> 300hh–17.  </td>

    <td> Emergency response coordination of primary care providers.  </td>

  </tr>

  <tr>

    <td> 

Part C—Strengthening Public Health Surveillance Systems  </td>

  </tr>

  <tr>

    <td> 300hh–31.  </td>

    <td> Epidemiology-laboratory capacity grants.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER XXVII—LIFESPAN RESPITE CARE  </td>

  </tr>

  <tr>

    <td> 300ii.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 300ii–1.  </td>

    <td> Lifespan respite care grants and cooperative agreements.  </td>

  </tr>

  <tr>

    <td> 300ii–2.  </td>

    <td> National lifespan respite resource center.  </td>

  </tr>

  <tr>

    <td> 300ii–3.  </td>

    <td> Report.  </td>

  </tr>

  <tr>

    <td> 300ii–4.  </td>

    <td> Authorization of appropriations.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER XXVIII—HEALTH INFORMATION TECHNOLOGY AND QUALITY  </td>

  </tr>

  <tr>

    <td> 300jj.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 

Part A—Promotion of Health Information Technology  </td>

  </tr>

  <tr>

    <td> 300jj–11.  </td>

    <td> Office of the National Coordinator for Health Information Technology.  </td>

  </tr>

  <tr>

    <td> 300jj–12.  </td>

    <td> HIT Policy Committee.  </td>

  </tr>

  <tr>

    <td> 300jj–13.  </td>

    <td> HIT Standards Committee.  </td>

  </tr>

  <tr>

    <td> 300jj–14.  </td>

    <td> Process for adoption of endorsed recommendations; adoption of initial set of standards, implementation specifications, and certification criteria.  </td>

  </tr>

  <tr>

    <td> 300jj–15.  </td>

    <td> Application and use of adopted standards and implementation specifications by Federal agencies.  </td>

  </tr>

  <tr>

    <td> 300jj–16.  </td>

    <td> Voluntary application and use of adopted standards and implementation specifications by private entities.  </td>

  </tr>

  <tr>

    <td> 300jj–17.  </td>

    <td> Federal health information technology.  </td>

  </tr>

  <tr>

    <td> 300jj–18.  </td>

    <td> Transitions.  </td>

  </tr>

  <tr>

    <td> 300jj–19.  </td>

    <td> Miscellaneous provisions.  </td>

  </tr>

  <tr>

    <td> 

Part B—Incentives for the Use of Health Information Technology  </td>

  </tr>

  <tr>

    <td> 300jj–31.  </td>

    <td> Immediate funding to strengthen the health information technology infrastructure.  </td>

  </tr>

  <tr>

    <td> 300jj–32.  </td>

    <td> Health information technology implementation assistance.  </td>

  </tr>

  <tr>

    <td> 300jj–33.  </td>

    <td> State grants to promote health information technology.  </td>

  </tr>

  <tr>

    <td> 300jj–34.  </td>

    <td> Competitive grants to States and Indian tribes for the development of loan programs to facilitate the widespread adoption of certified EHR technology.  </td>

  </tr>

  <tr>

    <td> 300jj–35.  </td>

    <td> Demonstration program to integrate information technology into clinical education.  </td>

  </tr>

  <tr>

    <td> 300jj–36.  </td>

    <td> Information technology professionals in health care.  </td>

  </tr>

  <tr>

    <td> 300jj–37.  </td>

    <td> General grant and loan provisions.  </td>

  </tr>

  <tr>

    <td> 300jj–38.  </td>

    <td> Authorization for appropriations.  </td>

  </tr>

  <tr>

    <td> 

Part C—Other Provisions  </td>

  </tr>

  <tr>

    <td> 300jj–51.  </td>

    <td> Health information technology enrollment standards and protocols.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER XXIX—DATA COLLECTION, ANALYSIS, AND QUALITY  </td>

  </tr>

  <tr>

    <td> 300kk.  </td>

    <td> Data collection, analysis, and quality.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER XXX—COMMUNITY LIVING ASSISTANCE SERVICES AND SUPPORTS  </td>

  </tr>

  <tr>

    <td> 300ll to 300ll–9.  </td>

    <td> Repealed.  </td>

  </tr>

  <tr>

    <td> 

SUBCHAPTER XXXI—WORLD TRADE CENTER HEALTH PROGRAM  </td>

  </tr>

  <tr>

    <td> 

Part A—Establishment of Program; Advisory Committee  </td>

  </tr>

  <tr>

    <td> 300mm.  </td>

    <td> Establishment of World Trade Center Health Program.  </td>

  </tr>

  <tr>

    <td> 300mm–1.  </td>

    <td> WTC Health Program Scientific/Technical Advisory Committee; WTC Health Program Steering Committees.  </td>

  </tr>

  <tr>

    <td> 300mm–2.  </td>

    <td> Education and outreach.  </td>

  </tr>

  <tr>

    <td> 300mm–3.  </td>

    <td> Uniform data collection and analysis.  </td>

  </tr>

  <tr>

    <td> 300mm–4.  </td>

    <td> Clinical Centers of Excellence and Data Centers.  </td>

  </tr>

  <tr>

    <td> 300mm–5.  </td>

    <td> Definitions.  </td>

  </tr>

  <tr>

    <td> 

Part B—Program of Monitoring, Initial Health Evaluations, and Treatment  </td>

  </tr>

  <tr>

    <td> 

subpart 1—wtc responders  </td>

  </tr>

  <tr>

    <td> 300mm–21.  </td>

    <td> Identification of WTC responders and provision of WTC-related monitoring services.  </td>

  </tr>

  <tr>

    <td> 300mm–22.  </td>

    <td> Treatment of enrolled WTC responders for WTC-related health conditions.  </td>

  </tr>

  <tr>

    <td> 300mm–23.  </td>

    <td> National arrangement for benefits for eligible individuals outside New York.  </td>

  </tr>

  <tr>

    <td> 

subpart 2—wtc survivors  </td>

  </tr>

  <tr>

    <td> 300mm–31.  </td>

    <td> Identification and initial health evaluation of screening-eligible and certified-eligible WTC survivors.  </td>

  </tr>

  <tr>

    <td> 300mm–32.  </td>

    <td> Followup monitoring and treatment of certified-eligible WTC survivors for WTC-related health conditions.  </td>

  </tr>

  <tr>

    <td> 300mm–33.  </td>

    <td> Followup monitoring and treatment of other individuals with WTC-related health conditions.  </td>

  </tr>

  <tr>

    <td> 

subpart 3—payor provisions  </td>

  </tr>

  <tr>

    <td> 300mm–41.  </td>

    <td> Payment of claims.  </td>

  </tr>

  <tr>

    <td> 300mm–42.  </td>

    <td> Administrative arrangement authority.  </td>

  </tr>

  <tr>

    <td> 

Part C—Research Into Conditions  </td>

  </tr>

  <tr>

    <td> 300mm–51.  </td>

    <td> Research regarding certain health conditions related to September 11 terrorist attacks.  </td>

  </tr>

  <tr>

    <td> 300mm–52.  </td>

    <td> World Trade Center Health Registry.  </td>

  </tr>

  <tr>

    <td> 

Part D—Funding  </td>

  </tr>

  <tr>

    <td> 300mm–61.  </td>

    <td> World Trade Center Health Program Fund.  </td>

  </tr>

</table>

----------

[Previous](./../../../..//us/usc/t42/ch6/m__us_usc_t42_s194.md) | [Next](./../../../..//us/usc/t42/ch6A/schI/m__us_usc_t42_ch6A_schI.md) | [Root of Title](./../../../../) | [Other Versions of this Document](https://publicdocs.github.io/go/links?ns=uslm&ref=%2Fus%2Fusc%2Ft42%2Fch6A)

----------
----------



